Next Article in Journal
L-Citrulline Supplementation and Exercise in the Management of Sarcopenia
Previous Article in Journal
Food-Based Dietary Guidelines around the World: A Comparative Analysis to Update AESAN Scientific Committee Dietary Recommendations
Previous Article in Special Issue
Effect of an Antenatal Lifestyle Intervention on Dietary Inflammatory Index and Its Associations with Maternal and Fetal Outcomes: A Secondary Analysis of the PEARS Trial
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Maternal Dietary Quality and Dietary Inflammation Associations with Offspring Growth, Placental Development, and DNA Methylation

by
Marion Lecorguillé
*,†,
Shevaun Teo
and
Catherine M. Phillips
School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin 4, Ireland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2021, 13(9), 3130; https://doi.org/10.3390/nu13093130
Submission received: 16 July 2021 / Revised: 31 August 2021 / Accepted: 4 September 2021 / Published: 8 September 2021

Abstract

:
The ‘Developmental Origins of Health and Diseases’ hypothesis posits that prenatal maternal diet influences offspring growth and later life health outcomes. Dietary assessment has focused on selected nutrients. However, this approach does not consider the complex interactions between foods and nutrients. To provide a more comprehensive approach to public health, dietary indices have been developed to assess dietary quality, dietary inflammation and risk factors for non-communicable diseases. Thus far, their use in the context of placental development is limited and associations with offspring outcomes have been inconsistent. Although epidemiological studies have focused on the role of maternal diet on foetal programming, the underlying mechanisms are still poorly understood. Some evidence suggests these associations may be driven by placental and epigenetic changes. In this narrative review, we examine the current literature regarding relationships between key validated diet quality scores (Dietary Inflammatory Index [DII], Mediterranean diet [MD], Healthy Eating Index [HEI], Alternative Healthy Eating Index [AHEI], Dietary Approaches to Stop Hypertension [DASH], Glycaemic Index [GI] and Glycaemic Load [GL]) in pregnancy and birth and long-term offspring outcomes. We summarise findings, discuss potential underlying placental and epigenetic mechanisms, in particular DNA methylation, and highlight the need for further research and public health strategies that incorporate diet quality and epigenetics.

1. Introduction

The importance of adequate nutrition during foetal life for long-term health is well documented [1]. The ‘Developmental Origins of Health and Diseases’ (DOHaD) hypothesis postulates that maternal nutritional status in the preconception period and during pregnancy may influence offspring development and the occurrence of disease, from childhood to later life [2,3,4,5]. More recently, research in DOHAD shows that environmental factors can affect the development of the next generation even before conception and into early childhood (the first 1000 days—from conception to two years). The Dutch famine studies have reported that women who were undernourished during pregnancy had increased risk of having children with intrauterine growth retardation (IUGR) [2]. Smaller size or relative thinness at birth or during infancy has been related to increased rates of cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) in adulthood [5,6,7,8]. Much attention has focused on the conditions of nutritional deprivation, but there is new evidence that maternal obesity during pregnancy is associated with long-term health consequences for the offspring, such as increased body mass index (BMI) during infancy, childhood and later life and increased risk of T2DM in adulthood [9,10].
Adequate maternal nutritional intake is an essential factor for a healthy pregnancy and optimal child development. However, dietary assessment is difficult to elucidate due to its complex interactions between diverse foods and nutrients [11]. To provide a more comprehensive approach to public health prevention, several aspects of dietary intake are measured against dietary recommendations (defined as ‘dietary quality’) [12,13]. Pregnancy is also known to alter the maternal inflammatory state, and unfavourable levels of pro-inflammatory cytokines may be in turn associated with pregnancy complications and adverse birth outcomes [14]. Diet has been recognised as an important modulator of chronic inflammation. Furthermore, having a more anti-inflammatory or less pro-inflammatory diet may reduce adverse outcomes during pregnancy, particularly in obese women [14,15].
Although epidemiological studies have focused on the role of maternal diet on foetal programming, underlying mechanisms are still poorly understood. Perturbations in the maternal environment may be transmitted across the placenta and thereby affect the development of the foetus. The placenta plays a fundamental role in maternal-foetal exchanges during pregnancy and an adequate maternal nutritional status is necessary to support placental homeostasis and development [16]. Altered placental structure and function may contribute to altered nutrient supply to the foetus [17].
Some evidence has shown that these associations may be also driven by epigenetic changes [18]. Epigenetic marks, in particular DNA methylation, appear to be particularly sensitive to environmental exposures during embryogenesis and cell differentiation [18,19]. Epigenetic data in humans are becoming increasingly robust but there is a challenge to continue exploring how specific factors (particularly nutritional factors in the prenatal period) may affect epigenetic mechanisms.
Thus, the aim of this narrative review is to examine and synthesize the literature regarding associations between maternal dietary quality, evaluated by several dietary scores, and dietary inflammation state with birth outcomes and long-term offspring health. We examine the underlying mechanisms including the placental dysfunction, which in turns impacts foetal growth, and the epigenetic mechanisms, more specifically DNA methylation, and conclude with future perspectives in this area of nutritional research

2. Materials

This is a narrative review of the current literature on the relationships between maternal dietary quality and dietary inflammation status and, birth and child outcomes, placental development and epigenetics. The literature search was performed in Pubmed, Web of Science, Scopus and the Cochrane database by using the following keywords separately or in combination: Maternal diet, nutrition, dietary inflammatory index, dietary quality scores (Dietary Inflammatory Index [DII], Mediterranean diet [MD], Dietary Approaches to Stop Hypertension [DASH], Healthy Eating Index [HEI], Alternative Healthy Eating Index [AHEI], Glycaemic Index [GI], Glycaemic Load [GL]), macronutrients, micronutrients, pregnancy, periconception period, foetal programming, child development, birth anthropometry, obesity, body mass index, placenta, epigenetic mechanisms, DNA methylation and cord blood. Relevant free-access abstracts were identified and peer-reviewed human studies, meta-analyses, systematic reviews and interventional studies were included. Other inclusion criteria were: (1) English language; (2) recording of the diet before or during pregnancy; (3) assessment of offspring measurements and prematurity; and (4) published papers within the last 15 years. Additionally, we included animal studies in our literature search in relation to maternal diet associations with placental outcomes and epigenetics. The websites of key government departments and agencies were consulted to identify important recommendations and reports such as the “Dietary Guidelines for Americans 2010”.

3. Maternal Diet and Indices of Dietary Quality and Dietary Inflammation

Optimisation of maternal diet during critical windows of development may positively impact on childhood weight status and future health trajectory [3,20]. However, the specific dietary requirements during pregnancy for optimal foetal growth and development are often limited in applicability and often prioritise macronutrient and micronutrient intake rather than food groups and dietary patterns. Most of the randomised controlled trials (RCTs) and observational studies have evaluated individual nutrient effects on foetal growth, with particular emphasis on avoiding certain micronutrient deficiencies [21,22]. Dietary patterns may provide a more comprehensive approach in public health for mother and infant as they have the potential to be used as a valid tool in assessing dietary associations with pregnancy outcomes [11,23]. Overall dietary quality may be more translatable to public health guidelines. Therefore, a variety of dietary scores and indices have been developed for nutritional epidemiology to assess dietary risk factors for non-communicable diseases [24,25,26,27]. These algorithms aim to evaluate the overall diet and categorise individuals according to the extent to which an individual’s eating behaviour is “healthy” based on primary nutritional data collected from 24-h quantitative dietary intake recalls, dietary records and food frequency questionnaires (FFQs) [28]. More recently, the dietary inflammatory index (DII®), was developed to characterise the inflammatory potential of the diet [25,29,30,31]. Here we describe dietary components, patterns and scores that reflect dietary quality and inflammation and their relevance in pregnancy.

3.1. Macronutrient Intakes in Pregnancy

Macronutrients are broadly defined as nutrients that provide calories or energy and are required in large amounts to maintain body functions and carry out the activities of daily life [32,33]. During pregnancy, the maternal diet must provide an adequate supply of energy to support the mother’s usual requirements as well as those of the growing foetus [21]. Extra energy is required for the synthesis of new tissue (foetus, placenta and amniotic fluid) and the growth of existing tissue (uterus, breast and maternal adipose tissue). Excessive energy intake should be avoided as it is the main determinant of gestational weight gain [21]. Hence, balancing and optimising protein and fibre as macronutrients could help with avoiding overnutrition during pregnancy, but these proportions need to be tailored based on pre-pregnancy weight, ethnicity, health literacy, BMI status and stage of pregnancy [21,33,34]. Special attention is warranted for the impact of carbohydrate intake in those with poor glycaemic control and at risk of gestational diabetes mellitus (GDM). During pregnancy, glucose transfer mainly occurs in the postprandial state, and glucose concentrations are determined by the carbohydrate foods [35,36]. The glycaemic index (GI) and glycaemic load (GL) qualify and quantify the postprandial glycaemic responses according to the dietary carbohydrate intake. Carbohydrates with low GI, for example whole grain breads, cereals and nuts, lead to a low glycaemic response, whereas foods such as confectionary and soft drinks lead to high glycaemic response [36,37]. Many systematic reviews have established the links between dietary GI/GL and the risk of chronic disease (such as T2DM, CVD and various cancers) but maternal carbohydrate quality has received relatively little attention [38,39]. Hence, further research is required in establishing the optimum timing to start a low-glycaemic index (GI) or glycaemic load (GL) diet for maximum protection against adverse pregnancy outcomes, in terms of insulin sensitivity, for both mother and infant [35,40].

3.2. Micronutrient Intakes in Pregnancy

Micronutrients are vitamins and minerals needed by the body in very small amounts to enable production of enzymes, hormones and other substances needed for normal growth and development [41,42]. Globally and even in high-income countries, an inadequate maternal micronutrient status is common with the evolution of food practices [41,43]. Studies in pregnant women in Germany and secundigravid women in Ireland showed that specific intakes of iron, folate vitamin D, vitamin B12 and iodine were below national guidelines, thus highlighting that multiple micronutrient deficiencies can still be prevalent in developed countries and targeted supplementation may be required in certain groups [44,45]. For example, foetal hypothyroidism (most commonly caused by iodine deficiency) may need to be addressed in the European population where only 8 out of 21 countries showed an adequate iodine status (38%) possibly due to low intake of iodine-rich seafood [46].
Folate is a key micronutrient for early stages of placental development [47] and the importance of periconceptional folate intake for child neurodevelopment has been widely recognised [48]. Folic acid supplementation is recommended in the preconception period (at least 3 months before becoming pregnant) and up to the 12th week of pregnancy, to prevent neural tube defects (NTD) and poor neurocognitive offspring outcomes [49,50,51].
Additionally, certain micronutrients are thought to play a role in epigenetic modification pathways including DNA methylation, thus establishing links between early nutrition programming and long-term health trajectories and disease risk [41,48]. Folate; vitamins B12, B2, and B6; betaine; choline; and methionine implicated in one-carbon metabolism (OCM) have been found to change DNA methylation in foetal tissues and in the placenta [19,48,52]. Finally, it has been shown that multiple-micronutrient supplementation may have beneficial effects on the reduction of low birth weight (LBW) and small for gestational age (SGA), [21,22]. Thus, transitioning towards multiple-micronutrient supplementation with evaluation of dietary indices is key in improving placental and neurodevelopment offspring outcomes [21,22,41,53].

3.3. Indices of Dietary Quality and Dietary Inflammation

An overview of dietary indices commonly used in the general population is presented in Table 1. The development and construction of these scores in the general population and in pregnant women are discussed further below.

3.3.1. Dietary Inflammatory Index (DII)

First validated in 2009 (Generation 1) [31] and later refined in 2014 (Generation 2, a version that includes an improved scoring system and an updated, more complete literature search) by Shivappa et al. [29], the DII combines a range of macronutrients and micronutrients with various non-nutrient naturally occurring chemicals (e.g., caffeine, flavanols) and herbs and spices (such as onion, turmeric, saffron, thyme, rosemary and green and black tea) [29]. The score represents the overall inflammatory potential of an individual’s diet based on 45 pro- and anti-inflammatory food parameters that either increased or decreased circulating biomarkers of inflammation (CRP, IL1β, IL4, IL6, IL10 and TNFα). The index is calculated using a scoring algorithm; a higher score indicates a pro-inflammatory diet, and a lower score indicates an anti-inflammatory diet. Usually, the DII is expressed as an energy-adjusted DII (E-DII) score because relations between energy and nutrient consumption (a key aspect in determining overall inflammatory potential of the diet) varies across age and according to total body mass [30]. It can be derived from any dietary assessment tool (e.g., food records, national surveys) and is universally applicable across all human studies with adequate dietary assessment [30]. It is important to identify and interpret scoring ranges of the DII used in studies because when calculated from all the 45 food parameters, DII scores can range from −8.87 to +7.98. To incorporate consistency in its interpretation, DII scores derived from 25–30 food parameters would lead to a more effective range of −5.5 to +5.5 [30]. Regardless, it is known that the effective range should rarely exceed 11 [30]. In this review, we focus on offspring associations with the refined (Generation 2) DII.

3.3.2. Mediterranean Diet (MD)

Several dietary metrics based on the MD have been created including the Mediterranean Diet Scale (MDScale) developed by Trichopoulou et al., Mediterranean Food Pattern (MFP), the MD Score (MDS), Mediterranean Lifestyle (MEDLIFE) index and the MedDiet score [54,55]. The Mediterranean dietary metric is based on epidemiologic findings of beneficial dietary effects on cardiovascular health, often localised to healthy eating guidelines [63]. The traditional main components are vegetables, legumes, fruits and nuts, unrefined cereals, olive oil, a moderate intake of fish, low to moderate intake of dairy products, a low intake of meat and poultry and moderate alcohol intake during meals. Differences noted between the various MD scores include number of components (nutrients, foods or food groups intake); classification categories for each item; measurement scales; statistical parameters (mean, median or tertiles of daily intake) and the contribution of each component (positive or negative) to the total score.

3.3.3. Healthy Eating Index (HEI)

Originally developed in 1995, the HEI evaluated adherence to key dietary recommendations from the Dietary Guidelines for Americans [64]. The original HEI was used to measure the overall dietary quality, but since then, the HEI has been modified regularly to reflect changes in dietary recommendations [65]. From 2005, the United States Department of Agriculture (USDA) versions of the HEI were based on an energy density approach [43,66]. The HEI-2010 score includes 12 components: 9 assess dietary adequacy (foods that people should consume more of) and 3 assess moderation (foods that people should consume less of) [56]. The HEI-2015 is the most recent iteration based on conformance with the 2015–2020 Dietary Guidelines for Americans [57]. The HEI-2015 uses a scoring system to evaluate food groups. Scores above 80 indicate a “good” diet, while scores below 51 indicate a “poor” diet [58]. An HEI score between 51 and 80 is considered as “needing dietary improvement”. The HEI-2010 and 2015 components are similar with the following exceptions in the HEI-2015: Saturated fat and added sugars replace empty calories and legumes are allocated to the two vegetable and the two protein foods components (thus highlighting the importance of a varied, balanced diet). Considering the overall similarities of the HEI-2010 and 2015 scores, similar diet–disease associations may be expected with both scores.

3.3.4. Alternative Healthy Eating Index (AHEI)

Compared to the HEI, the AHEI-2010 incorporates foods, nutrients, dietary recommendations predictive of chronic disease risk (i.e., T2DM) and mortality [58]. It consists of 11 components of varying proportions: Six components for which higher intakes are better (vegetables, fruit, wholegrains, nuts and legumes, long chain omega-3 fatty acids (FA) that include docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) and polyunsaturated fatty acids (PUFA)); one component for which moderate intake is better (alcohol); and four components that must be limited or avoided (sugar sweetened drinks and fruit juice, red and processed meat, trans fats and sodium) [58]. Hence, the AHEI emphasises diet (predominantly fat) quality (i.e., intakes of omega-3 FAs and PUFAs) and promotes the intake of nuts and legumes using a food-based dietary guideline approach. This could be important in reducing adverse outcomes for infants for women who are at greater risk of gestational diabetes and hypertensive disorders of pregnancy [58,66]. In addition, the AHEI-2010 recommends limiting the intake of red and processed meats and to avoid added sugars (i.e., sugar-sweetened beverages and fruit juice), both of which have been associated with pro-inflammatory states and the risk of overnutrition coming from excess prenatal sugar intakes [67,68].

3.3.5. Dietary Approaches to Stop Hypertension (DASH)

The DASH score was developed for the therapeutic reduction in blood pressure based on dietary patterns and food/nutrient components from the DASH Trial [61]. It is promoted as a healthy option for the general population as a therapeutic means of controlling high blood pressure without the use of medication. The DASH score created by Fung et al. [60] is the most commonly used dietary score in the literature and is relevant to the pregnant population as it was calculated based on a middle-aged female population in the US (a Western developed, industrialised nation) [60,69]. It uses scoring based on the quintile distribution of intake on the following eight components: A high consumption of fruits, vegetables, nuts and legumes; low-fat dairy products and whole grains; and a low consumption of sodium, sweetened beverages and red and processed meats [26]. A DASH score between 8 to 40 (indicative of lowest and highest adherence respectively) ranks participants according to their dietary intakes.

3.3.6. Modified Dietary Scores for Pregnancy

Many of the aforementioned dietary scores have been modified and adapted for characterising maternal diet quality during pregnancy. Mediterranean diet scores such as Trichopolou’s MDS and Khoury’s score have often been modified in observational studies for pregnancy to provide the most useful information in terms of conceptual suitability and applicability [55]. For example, the original a priori Trichopolou’s MDS and the KIDMED index (another MD score validated in younger individuals [2–24 years]) have been modified to consider dairy to be protective due to increased calcium requirements during pregnancy and hence is scored positively [70,71,72], whereas nuts can sometimes be excluded from dietary scores (Khoury and AHEI for pregnancy) as some women may avoid nuts during pregnancy out of concern for allergen sensitisation [73,74,75]. The HEI-SGP (generated based on dietary guidelines and recommendations for pregnant women in Singapore) and the Alternate Healthy Eating Index for Pregnancy (AHEI-P) are conceptually similar to the standard HEI except they include adherence to antenatal supplementation of key micronutrients (iron, folate and calcium) in their scoring [20,75,76]. These scores have been shown to be useful in identifying women ‘at risk’ of poor blood glucose control and pre-eclampsia during pregnancy, who would benefit from early intervention with multiple-micronutrient supplementation [75,76]. The DASH dietary pattern, modified in line with trends observed in the pregnant population such as limiting sugar-sweetened beverage intake, has also been shown to improve glucose tolerance and lipid profiles of women with GDM [77,78]. In the ROLO study, a DASH dietary pattern during pregnancy was associated with lower maternal blood pressure among healthy women without hypertensive disorders of pregnancy [79].
In summary, these specific dietary metrics all share certain characteristics such as a diet high in vegetables, legumes and fruits, indicative of better diet quality and sustained habits, and were associated with one or more important maternal health outcomes such as pre-eclampsia, GDM, altered blood glucose metabolism and postpartum obesity [70,75,79,80,81,82,83]. Additionally, most of these pregnancy-specific dietary tools account for adequacy of key food groups and micronutrients that favour maternal and child health and can serve as useful tools to indicate adherence to national healthy eating recommendations [20,75,76,84].

4. Maternal Dietary Metrics and Offspring Birth Outcomes

As mentioned above, studies investigating maternal diet have mainly focused on adequate intake of selected macronutrients and micronutrients during pregnancy. In recent years, there has been growing interest in examining associations between overall maternal diet quality (by using the previously described scores) and child development. Here we summarise the literature regarding the relationship between maternal dietary quality and dietary inflammatory potential with birth outcomes related to growth and prematurity.

4.1. Dietary Inflammatory Index

Chronic inflammation during pregnancy that is observed in obese women may alter physiological mechanisms of the developing foetus. Obesity-induced inflammation is characterised by abnormal cytokine and adipokine levels [85]. Some studies have shown that a higher DII or E-DII score indicating a more anti-inflammatory diet may ameliorate the pro-inflammatory state of pregnancy, particularly in obese women [14,15]. A detailed description of the studies outlined below is reported in Table 2. The Healthy Start Study (n = 1078 mother–neonate pairs) reported that higher DII scores in obese mothers during pregnancy were associated with increased neonatal adiposity [86], while the NEST study (n = 1057 mother–child pairs) did not report associations with birth anthropometry but an increased risk of prematurity among female offspring was observed [14]. Conversely, in the Lifeways study, higher maternal E-DII scores in early pregnancy were associated with increased risk of low birthweight [24]. Additionally, results from the Project VIVA showed that higher DII scores were associated with lower birth weight for gestational age z score in infants born to obese mothers [15]. There are limited investigations of maternal DII and its influence on birth outcomes, and results remain inconsistent. However, a recent meta-analysis of individual participant data on 24,861 mother–child pairs, in seven European cohorts, has been recently conducted [87]. A higher maternal pre-pregnancy E-DII score was associated with lower birth weight [β(95% CI) = −18.7(−34.8, −2.6) g per 1-SD higher E-DII score] and shorter birth length [−0.07(−0.14, −0.01) cm], whereas a higher E-DII score during pregnancy was associated with an increased risk of LBW [odds ratio (OR)(95% CI) = 1.14(1.04, 1.26) and being small for gestational age (SGA) [OR(95% CI) = 1.18(1.11, 1.26)] and shorter birth length [−0.06(−0.10, −0.01) cm. These findings, which were robust across a range of sensitivity analyses, highlight the importance of having a less pro-inflammatory diet not only during pregnancy but also before becoming pregnant.

4.2. Mediterranean Diet

Some studies have examined the potential benefits of the Mediterranean diet on foetal development, considering the MD as a whole rather than focusing on the effect of its individual components. Foetal growth restriction (FGR) and SGA were the main outcomes examined. In a prospective observational study of 3207 Caucasian pregnant mothers in Rotterdam, low adherence to a MD in early pregnancy was associated with decreased intra-uterine size with a lower placental and a lower birth weight [88]. Inversely, in the INMA-Mediterranean cohort in Spain, mothers with high MD adherence had a significantly lower risk of having foetal growth restricted infant at birth [89]. However, the previous results were not consistent in the INMA study from the Atlantic area and the RHEA cohort in Greece [89]. One limitation of these studies is that the MD is subject to some regional variations associated with sociocultural, population and geographic differences. MD scores during pregnancy were not homogeneous, with women in the Atlantic area reporting higher intakes of fish and dairy products, while women in Greece reported higher intakes of fruits and nuts. These observations could explain in part the different results in population. However, in all cohorts, they showed a protective effect of adherence to MD in smokers that may counter the effect of oxidative stress damage on foetal tissues [89].
Other studies reported associations between maternal MD and prematurity. In a study from the French West Indies, where dietary patterns present several characteristics of the MD diet, no overall associations were found between MD adherence and birth weight. However, there was a decreased risk of prematurity associated with greater MD in overweight and obese women [90]. In the observational cohort of 35,530 Danish women, Mikkelsen et al. showed a 72% reduction in the risk of early preterm delivery (<35 weeks of gestation) in women who fulfilled all MD criteria, compared to women fulfilling none of the MD criteria during pregnancy [91]. Meanwhile, another study in Norway, which defined MD with the same criteria as the previous study, showed no association with risk of prematurity [73]. However, several hypotheses explaining the potential link with reduced risk of prematurity have been described. In particular, one randomized trial has evaluated the effect of a cholesterol-lowering diet on maternal pregnancy outcomes. In that study, women in the intervention group were advised to change their diet towards a Mediterranean-type diet. A diet enriched with n-3 (omega-3) PUFA may influence the level of inflammatory cytokines, which are involved in the pathophysiological mechanisms of prematurity and reduced its incidence [74]. Most studies focused on evaluating birth weight or prematurity; however, a recent study showed that greater MD adherence was positively associated with birthweight, length and sum of skinfold thickness, a measure that better captures total neonatal adiposity [92]. A detailed description of the previous articles (non-exhaustive list) is reported in Table 3.
To conclude, two recent systematic reviews of literature reported growing evidence of the potential benefits of the MD diet for child development, but other randomized trials are needed to confirm these results [80,98]. Moreover, the strength of the association varied in the different studies, which can be affected by high heterogeneity related to the methodology used for the MD assessment. The number of food items included in the FFQ, the way of administration and the calculation of consumed foods may explain some differences between results. Another confounding factor is the period of pregnancy considered for evaluation of MD adherence [98].

4.3. HEI, AHEI and AHEI-P Scores

Several studies have examined birth outcome associations with these dietary indices (see Table 4). In a Spanish cohort, Rodriguez-Bernal et al. found that increasing quintiles of the AHEI-P score were associated with higher birth weight and length [99]. However, the results remain inconsistent, with several studies reporting no association between maternal AHEI-P or AHEI-2010 scores and anthropometry measurements at birth [75,100,101]. Other studies reported that low maternal HEI-2010 scores were associated with offspring adiposity and risk of being large for gestational age (LGA) [102,103]. Most of the studies of maternal diet quality during pregnancy used previous versions of HEI scores, while another study reported a lower risk of LBW with a high adherence to the HEI-2015 [104]. Variations in the dietary assessment, as some of them were updated for pregnancy and participant characteristics, are the main contribution to the discordance in the results. However, higher adherence to these indices have been strongly linked to a greater dietary variety and consumption of essential nutrients that may lead to a favourable cardiometabolic profile in pregnant women [103].

4.4. DASH

A systematic review and meta-analysis of RCTs provides evidence that the DASH diet could play a role in glycaemic control and improve gestational outcomes in women with cardiometabolic disorders such as GDM, hypertension or obesity [107]. Among the studies included, one revealed that adherence to the DASH diet for 4 weeks among pregnant women with GDM was associated with improved fasting glucose profile and reduce the use of insulin therapy. Mean birthweight, head circumference and ponderal index of infants born in the intervention group were significantly lower compared with those born to mothers in the control arm [78]. Other observational and RCTs report that adherence to the DASH diet in women with risk factors (obesity, hypertension) was associated with lower birthweight or birth length, a lower risk of prematurity or having a LGA infant [82,108]. Inversely, another RCT conducted in a group of overweight and obese women failed to demonstrate improved birth outcomes with a DASH diet, even when a reduction of gestational weight gain was observed [109]. A description of the few studies included is shown in Table 5. The published literature on the relationship of the DASH diet with birth outcomes remains inconsistent. Differences between studies regarding the diagnosis of GDM, hypertension or obesity might explain fundamental physiological differences between the included women [110]. Future studies including more generalisable populations are needed to ascertain the effect of the DASH diet [107]. A recent meta-analysis of the ALPHABET European project, conducted in a general population of pregnant women, has shown that a higher pregnancy DASH score was associated with higher birth weight [β (95% CI) = 18.5 (5.7, 31.3) g per 1-SD higher DASH score] and head circumference [0.03 (0.01, 0.06) cm], as well as longer birth length [0.05(0.01, 0.10) cm], and lower risk of delivering SGA [0.87(0.82, 0.94)] infants [87].

4.5. GI/GL

A recent meta-analysis of 11 randomized trials including 1985 women has shown that compared with control diets, a low GI diet significantly reduced fasting and 2-h postprandial blood glucose levels and proportion of LGA infants [36]. However, some of the RCTs were conducted mostly in high-risk populations (with a history of gestational diabetes or previous macrosomic infant) and differed in terms of study design, which may contribute to heterogeneity among the studies and may partly explain the inconsistent results [81,112] (Table 6). The ROLO study is an RCT of 800 secundigravida women who had previously given birth to a macrosomic baby (>4 kg), randomised to low GI dietary advice vs. usual antenatal care, which did not involve dietary advice [81]. No differences between groups were reported in birth weight or 6-month offspring adiposity [81,113], whereas another RCT conducted in women with diabetes showed a trend of lower birth weight after a low GI carbohydrate intervention compared to all types of carbohydrates [112]. Other observational studies reported controversial results between GI/GL and birth outcomes [35,38,40,83]. A prospective cohort in Ireland evaluated the associations between maternal GI, GL, insulinemic index/load (II, IL) and offspring birth outcomes. Dietary II and IL may play an important role in blood glucose regulation [38]. No associations between glycaemic or insulinemic indices during early pregnancy with birth weight, BMI at birth or gestational age were observed [38]. In summary, some studies indicate reduced risk of adverse neonatal outcomes following a low-GI dietary intervention. However, the evidence is limited, and results should be interpreted with caution because of the evidence of heterogeneity across studies.

5. Maternal Dietary Metrics and Offspring Childhood Outcomes

In line with the DOHaD hypothesis, maternal diet associations with offspring health may not be restricted to birth and may have longer term implications. Here we summarise the literature regarding the relationship between maternal dietary quality metrics and dietary inflammatory potential with offspring outcomes related to childhood growth and obesity. A summary of the studies and their key findings is presented in Table 7.

5.1. DII

Data regarding long-term associations of maternal dietary inflammation with offspring anthropometric outcomes are scarce. Sen et al. reported positive associations between maternal DII (measured during the first and second trimesters) and offspring anthropometric measures in mid-childhood (between ages 6 and 10), which included BMI z-score and waist circumference as well as more direct measures of adiposity such as fat mass index, fat-free mass index (FFMI), trunk fat mass index and fasting insulin [84]. The E-DII score was also recently analysed in the ALPHABET Consortium in 16,295 mother–child pairs from seven European birth cohorts. Higher early-pregnancy E-DII scores (indicating a more pro-inflammatory diet) tended to be associated with a higher odds of late-childhood [10.6 (1.2) years] overweight and obesity (OWOB) [OR (95% CI) 1.09 (1.00, 1.19) per 1-SD E-DII score increase], whereas an inverse association was observed for late-pregnancy E-DII score and early-childhood [2.8 (0.3) years] OWOB [0.91 (0.83, 1.00)]. In two cohorts with available data, a higher whole-pregnancy E-DII score was associated with a lower fat-free mass index in both mid-childhood and late-childhood [123]. In the Irish Lifeways cohort, there were no associations found between maternal dietary inflammation during pregnancy and childhood adiposity, whereas paternal line dietary inflammation appears to influence childhood obesity at both 5 and 9 years [24].

5.2. Mediterranean Diet Score

Chatzi et al. studied anthropometric outcomes in 997 mother–child pairs in the American Project Viva study in conjunction with 569 mother–child pairs from the Greek Rhea study. They found that maternal adherence to the MD during pregnancy was associated with lower child adiposity, leptin and blood pressure levels [120]. It is important to note that the Greek cohort is based on outcomes in early childhood at around 4 years compared to the American median age of 8 years. However, they report that these associations of MD scores in pregnancy with offspring adiposity were broadly similar in both cohorts when studied separately [89,120].
The analysis of results from the Growing Up Today Study II across follow-up ages of 12–23 years indicate that greater maternal adherence to the Alternate Mediterranean Diet (aMED) score (adapted to the US population) showed similar findings with a lower risk of offspring overweight or obesity [116]. However, the results were not significant following adjustment for potential confounders including maternal pre-pregnancy BMI and lifestyle factors. It should be noted that childhood weight measures were self-reported in the study, which may lead to underreporting amongst adolescents with obesity [116]. In a Spanish study predicting long-term health outcome risks, the importance of tracking childhood adiposity rather than crude weight alone is underscored, because cardiometabolic risk factors are more prevalent in children and adolescents with abdominal obesity than those with general overweight/obesity [121,124,125]. The researchers reported that higher adherence to the relative Mediterranean diet score (rMED) in pregnancy was not associated with offspring overweight status at age 4 years. However, there was some evidence of an inverse, moderate association between the rMED in pregnancy and offspring waist circumference, a marker of abdominal obesity [121]. Furthermore, Donahue et al. have demonstrated a protective effect of prenatal omega-3 PUFAs (which is a key macronutrient in the Mediterranean diet) on adiposity in 3-year-olds [126].

5.3. HEI and AHEI Scores

Tahir et al. report that higher HEI-2015 scores during the third trimester of pregnancy were associated with lower infant body fat percentage at six months [119]. However, another study by Gonzalez-Nahm et al. in an American cohort found no association between AHEI-2010 scores in mid to late pregnancy and infant adiposity at birth, 6 or 12 months after adjustment for confounders such as maternal smoking, pre-pregnancy BMI, maternal ethnicity and maternal education [118]. Similarly, retrospective analysis by Strohmaier et al. found no associations between peripregnancy maternal adherence to the AHEI-2010 and offspring risk for obesity 12–23 years after adjustment for pre-pregnancy BMI and lifestyle factors [116]. Long-term studies using the modified AHEI-P are not yet available.

5.4. DASH Score

Despite its importance in controlling blood pressure and placental vascular flow, research regarding maternal DASH score associations with offspring adiposity and childhood obesity are scarce. Strohmaier et al. report an inverse association between peripregnancy DASH scores and offspring overweight risk at 12–23 years; however, this association was no longer observed after adjusting for maternal BMI and lifestyle factors before pregnancy [116]. Recent results from the ALPHABET Consortium in 16,295 mother–child pairs from seven European birth cohorts showed that higher maternal DASH score during pregnancy was associated with a lower odds of late-childhood OWOB (age-and-sex-specific BMI z-score >85th percentile) as well as a lower late-childhood fat mass index (FMI) [123]. Interestingly, no consistent associations were observed between maternal DASH scores with regards to early- and mid-childhood OWOB (mean age range 2.8–6.1 years) [123].

5.5. GI/GL

Results from the Southampton Women’s Survey of 907 mother–child dyads identified associations between higher maternal GI and GL with greater offspring adiposity (body-fat mass) at 4 and 6 years [122]. These results were found with early, but not late pregnancy GI and GL, highlighting the importance of the timing of the dietary assessment during pregnancy in the programming of adult disease susceptibility. However, more recent observational research based on the Lifeways cohort of generally healthy pregnant women found no clear associations between maternal GI and GL with childhood BMI, waist circumference z-scores and general or central obesity at 5 years [38]. In the Danish National Birth Cohort, higher maternal GI and GL were associated with an increase in 7-year BMI z-score in the unadjusted analysis. However, this association was no longer present after adjusting for previously mentioned confounders, particularly maternal pre-pregnancy BMI [117]. Similarly, a secondary adjusted analysis of the Irish ROLO cohort found no evidence that a low-GI diet in pregnancy impacts offspring anthropometry and body composition outcomes after 5 years’ post-intervention [115]. Limited and inconsistent literature exist regarding maternal dietary scores and long-term childhood outcomes related to weight status and adiposity.

6. The Role of the Placenta during Pregnancy

6.1. Placental Development

The placenta plays a fundamental role in the various maternal-foetal exchanges during pregnancy and has endocrine functions that are essential for the maintenance of the pregnancy as well as for the development of the foetus [16]. Together with the umbilical cord, it provides for the direct transfer of nutrients, hormones and wastes between the mother and offspring. Originally formed from trophoblast cells during the implantation phase, the growth rate of the placenta is most rapid in the first trimester of pregnancy, a time when placental tissues are most sensitive to environmental perturbation [127,128]. Inadequate maternal nutrition or weight status can have major effects on the balance between the nutritional needs of the foetus and the placental capacity to meet them [41,129].
Different markers of altered placental function reflected by weight, morphology, vascular development and transport function have been described. Markers of modifications in placental transport capacity include alterations of exchange surface area, barrier thickness and cell components of the different gestational ages of the placenta. These histopathological changes predispose to reduced nutrient transfer to the foetus. Additionally, vasculogenesis and angiogenesis are both critical processes to the maternal-foetal exchange. Vasculogenesis is de novo formation of blood vessels in the developing embryo while angiogenesis corresponds to new vessels from pre-existing vessels [17]. The foetal (birth weight) to placenta weight ratio at different gestational ages of placental development also been used, but collecting these measurements is often difficult in human studies [17,130]. Therefore, placental weight has been described as the most practical, studied marker of the available surface area for maternal foetal nutrient exchange [130,131,132]. Despite not being the only marker available, investigating the effects of dietary quality on placental weight could provide important insights, which may inform dietary guidelines or interventions to help prevent abnormalities in placental and subsequent child development.
Alterations in maternal nutritional status, such as undernutrition, have been described as impairing placental development and function, including placental weight, its function in transporting various nutrients, as well as its vascular development (de novo vessel formation) and the process of angiogenesis [17]. The pathogenesis of blood flow dysfunction such as pre-eclampsia may be established in early pregnancy when an inadequate remodelling of the spiral arteries occurs and leads to decreased perfusion of the placenta and development of the maternal syndrome in later pregnancy [133]. Oxidative stress and inflammatory mediators are also involved in the abnormal implantation associated with pre-eclampsia and IUGR, thus highlighting the role of diet quality in optimal implantation and placentation during the preconceptional period [41,133]. Consequently, inadequate placental development could lead to inappropriate foetal development and risk of IUGR [41,129,133]. Assessing the underlying vascular and inflammatory mechanisms associated with placental perfusion and transport efficiency is difficult in humans and most research has been limited to experimental animal models, specifically rats, mice and sheep. Conversely, other studies showed that maternal nutritional conditions such as hyperglycaemia and hyperinsulinemia are also likely to contribute to alterations in placental growth and weight [134]. However, more research is needed in investigating how early nutritional and metabolic change during pregnancy may affect placental development and lead to excessive neonatal adiposity. It is also important to note sex-specific placental adaptations that may drive differences in offspring growth [135]. In females, increased foeto-placental adaptability and placental reserve capacity result in increased survival rates at the expense of a reduced growth trajectory, whereas the opposite is observed in males [135]. Recent studies highlighted that sexual dimorphism may play a role in the impact of the placenta on infant anthropometry at birth, with significant findings seen in males but not females [136].

6.2. Maternal Diet and Placental Development: Evidence from Animal Studies

Starting with animal studies, some researchers have looked at the associations between high-fat diet or micronutrient and placental development [137]. Feeding pregnant rats a ‘junk’ food diet, characterised by high fat, high sugar and high salt, has demonstrated increased risk of adiposity in adult offspring [138]. These energy-dense diets often lead to overnutrition that is thought to elicit metabolic disturbances in placental development as well as foetal hyperglycaemia and hyperinsulinemia [127,128]. Across periconceptional rodent studies, there were no differences in foetal and placental weights where high-fat diets were given to rats compared to the control [139,140]. However, altered placental gene expression, with pathways promoting inflammation and growth being over-represented among up-regulated genes and those affecting apoptosis among down-regulated genes, has been observed following maternal high-fat feeding in pregnant rats [139]. Thus, multiple rodent studies highlight the impact of a high-fat diet on placental metabolism and thus on foetal programming for long-term offspring adiposity [141,142].
Other studies also evaluated the effect of specific micronutrients on placental development and inflammation. Reduced placental weight has been reported in severe iron deficiency in rats [137]. This is of note as further rat studies show that anaemia induces oxidative stress and inflammation in rat placentas, with elevated circulating levels of pro-inflammatory IL-6 and TNF-α as well as oxidative damage (lipid peroxidation) and reduced antioxidant status [137,143]. Folate is directly able to scavenge free radicals while B vitamins (B2, B6 and B12) also have antioxidant activity, thus playing an important role in early stages of placental development, including trophoblast invasion and angiogenesis [47,133]. Moreover, folate-deficient mice were found to have decreased foetal weight and foetal/placental weight ratio [144]. Folate in particular is thought to play a key role in placental angiogenesis (critical for development of a normal placental circulation) by increasing the bioavailability of nitric oxide [17,47]. This is an important endothelium vasodilator, and its decreased bioavailability is associated with the production of reactive oxygen species involved in poor placental development [133,145]. Furthermore, maternal vitamin B12 deficiency in rats altered placental phospholipid ratios, underscoring the potential of micronutrients in influencing placental development and composition [137].

6.3. Maternal Diet and Placental Development: Evidence from Human Studies

Maternal nutritional status during pregnancy plays a major role in foetal development, and accumulating evidence suggests that maternal hyperglycaemia may have adverse effects on embryonic and placental development [35]. Observational studies in the UK and Ireland have found that high carbohydrate intake during pregnancy could impair maternal insulin sensitivity, making higher levels of free glucose available for placental circulation, subsequently activating foetal glycogenesis and contributing to excess neonatal adiposity [21,67,146]. Such maternal overnutrition and as well as diabetes can also cause transient physiologic proinflammatory oxidative stress in the trophoblast, leading to a reduction in trophoblast growth in the placenta [128,134]. The link between dietary fat composition (fatty acid quantity and quality) and chronic disease risk is well established [147,148]. Maternal dietary fat intake has been shown to affect the fatty acid composition of lipids in foetal and newborn blood and developing tissues. By affecting the fatty acid supply to the foetus, differentiation in organs including the placenta can occur, which may in turn influence placental development and foetal programming [127,148].
Excessive omega-6 fatty acid intake and insufficient omega-3 fatty acid intake are two key components that adversely affect foetal programming [148]. An Icelandic observational study reported an inverse association between the proportion of long-chain omega-3 PUFAs in red blood cells of women in the 11th to 15th week of pregnancy and placental weight [133]. A moderate maternal dietary protein intake (10–25% of total energy) is optimal for foetal growth and survival, as both low but also high protein intakes have been associated with lower birth weights and IUGR [21,149]. Possible mechanisms include reduced placental angiogenesis and reduced supply of nutrients from mother to foetus for low protein intakes. High maternal concentrations of amino acids (AA) leads to competition for AA transporters, resulting in reduced placental transport and umbilical uptake of AAs [149].
Other studies have evaluated the effect of micronutrients on placental development. In a prospective study of 1650 pregnancies, low iron status in early pregnancy was inversely related to placental size [150]. The synergistic use of vitamin E and vitamin C as antioxidants are important to consider in placental development due to their effect of inhibiting free radical formation to prevent oxidative stress and inflammatory placental damage [21]. Studies have demonstrated reduced placental perfusion and risk of pre-eclampsia arising from the placenta’s limited antioxidant enzyme capacity in the first trimester [133]. The micronutrient immunomodulatory effects of Vitamin A, Vitamin D, folate and B12 in in vitro/in vivo models of deficiency have also all demonstrated pro-inflammatory effects in the placenta including upregulation of pro-inflammatory cytokines [137].
However, research on maternal dietary score associations with placental development is scarce. In the Generation R cohort, women with low adherence to a Mediterranean diet pattern during early pregnancy had smaller placentas and also tended towards higher uteroplacental vascular resistance compared to those with high adherence to the MD pattern. However, it is important to note that an established, validated MD score was not used in this study [88]. Recent observational analysis in the same Dutch cohort found that in mid- and late- pregnancy, a higher maternal DASH diet score based on Fung’s scoring method tended to be associated with lower umbilical artery vascular resistance and that lower maternal DASH score quartiles were associated with a higher umbilical artery pulsatility index (UmPI) [151]. The UmPI reflects the development of the fetoplacental vascular tree. Studies using the DII are more limited but early research suggests that oxidative stress or inflammation caused by a pro-inflammatory diet results in higher resistance and lower flow placental circulation [15]. This resultant mechanism leading to adverse foetal growth is thought to be more pronounced in obese pregnant women, who experience higher baseline inflammation and oxidative stress [15]. Further research on all of these validated maternal dietary score associations with placental development and inflammation is warranted.

7. Epigenetic Mechanisms

In 1942, Conrad H Waddington defined epigenetics as “the branch of biology that studies the causal interactions between genes and their products which bring the phenotype into being” [152]. Epigenetics was subsequently defined as the study of the mechanisms that regulate gene expression without alteration in the DNA sequence [153]. Epigenetic processes are essential for many organisms functions, but can be associated with major adverse health effects if they occur inappropriately [154]. Three main mechanisms are described in the literature: DNA methylation, histone modifications and noncoding RNAs [155]. DNA methylation, which is currently the easiest marker to measure and therefore the most studied in epidemiological studies, is the focus of this review.

7.1. DNA Methylation and Developmental Plasticity

Epigenetic modifications have been proposed as mechanisms by which a suboptimal nutrition state could contribute to the “developmental plasticity of the individual”. Early-life exposures have been described to be recorded in the “cellular memory” and having the potential to influence cellular functions with long-term effects [18,156]. The periconceptional period is a particular sensitive period for environmental exposures, due to major epigenetic processes that take place at the beginning of pregnancy [18]. Upon fertilisation, a global demethylation is observed, followed by de novo genome-wide methylation after implantation [18]. Thereafter, new methylation patterns are established from pluripotent cells in a lineage-specific manner leading to organ and tissue differentiation [18,157]. However, other studies showed that epigenetic marks are dynamic and modifiable under environmental conditions throughout the pregnancy and development [158] Several discoveries have highlighted the importance of DNA methylation for embryonic development, cell differentiation during development and the maintenance of tissue-specific gene expression patterns [18,159]. An inadequate environment during the periconception period may have an impact on epigenetic mechanisms, foetal programming and future health. Thus, the in utero environment, in particular maternal nutrition, has been described as one of the important factors in the modulation of gene expression [157]. This chapter reviews the current state of knowledge of maternal nutrition in DNA methylation changes. This review includes studies related to over- or undernutrition, glycaemic markers, the one-carbon metabolism (OCM) nutrients and a focus specifically on dietary quality and inflammation.

7.2. Maternal Nutritional Intake and DNA Methylation

The first evidence is based on findings from animal studies. Murine models have provided evidence about how early nutritional exposure is involved in epigenetic mechanisms, programming of the individual and its phenotype [18]. A classic example is the agouti gene, which is involved in determining coat colour in mice. In genetically identical mice, some have a brown coat and others a yellow coat [18]. The agouti viable yellow mouse is characterised by a yellow coat colour and an increased risk of obesity and hyperinsulinaemia. This is caused by a dominant mutation of the agouti locus, caused by the insertion of a so-called IAP (intracisternal A particle) repeat element, which acts as an alternative promoter. Hypomethylation of the promoter led to overexpression of the gene involved in the regulation of yellow pigment and other effects including obesity [18]. Conversely, when the percentage of methylation increases, the synthesis of the yellow pigment is regulated downwards, resulting in a brown or “pseudoagouti” coat [18]. One study showed that methyl-donor supplementation (folic acid, vitamin B12, choline and betaine) was associated with hypermethylation of the agouti gene [160].
Recent human data are becoming available regarding the associations between maternal diet and DNA methylation. It has been described that some micronutrients are implicated in the one-carbon metabolism pathway, which supports multiple physiological processes, essential for human development including DNA methylation [19,161]. The main studies have focused on the associations between individual micronutrients, methyl-donors and DNA methylation and the role of maternal over- and undernutrition. However, there are a limited number of human studies that have evaluated the relationship between dietary quality or inflammation state and offspring epigenetics.

7.2.1. One-Carbon Metabolism Nutrients

The Pune Maternal Nutrition Study cohort in India have provided evidence of the importance of the one-carbon metabolism in foetal programming [53]. OCM nutrients are described as carriers or methyl-group donors (e.g., folates, choline, betaine, methionine), or cofactors of enzymes involved in the transfer reactions of the methyl-groups to DNA (vitamins B2, B6, and B12) [19]. Some studies have shown the implication of these micronutrients in offspring DNA methylation. Maternal dietary and supplemental intake of methyl-groups donors (folate, folic acid, betaine) in the preconception period can influence an infant’s buccal DNA methylation patterns at 6 months old. The identified genes were associated with development, metabolism and appetite control [162]. In Gambia, it has been found that significant seasonal variations in maternal methyl-donor nutrient intake around the time of conception may influence levels of DNA methylation at metastable epialleles in offspring [163,164]. Metastable epialleles are genomic regions whose expression is determined in the early embryo and independently of cell differentiation [165]. Modifications at metastable epialleles can lead to permanent phenotypic consequences [163,165]. Another study has investigated the relationship between serum levels of folate, vitamin B12 and methylation of the imprinted genes insulin-like growth factor 2 (IGF2) in maternal and cord blood. IGF2 is a key factor in human growth and development. The methylation patterns of IGF2 in promoter 3 of cord blood samples were negatively associated with serum levels of vitamin B12 only in maternal blood [166]. Other results reported significant associations between maternal folic acid intake in early pregnancy and offspring DNA methylation in the control of imprinted genes (IGF2) and transposable elements such as long interspersed nuclear element 1 (LINE-1) [18,167]. One RCT has confirmed these results by showing that folic acid supplementation during pregnancy compared with placebo results in significant changes in cord blood DNA methylation in genes involved in growth and brain development [168]. However, most of the previous studies are observational and, thus, by design cannot provide direct causal link between micronutrient intake and epigenetic effects in offspring. Moreover, further research is needed investigating the combined intake of OCM nutrients, the interactions among nutrients and those that may indirectly affect the DNA methylation process [19].

7.2.2. Interventional Studies on Glycaemic Index

In recent years, some interventional studies have focused on the impact of GI dietary intervention in mothers during pregnancy and evaluated their relation to DNA methylation in the progeny. Exposure to adverse conditions during pregnancy like GDM is increasing and has been largely shown to affect foetal development [169]. New evidence also supports the epigenetic role in metabolic development of newborns exposed to maternal hyperglycaemia during pregnancy [169]. The ROLO study, an RCT, investigated the impact of a low GI dietary intervention during pregnancy on DNA methylation in cord blood at birth by using a genome-wide approach [170]. No individual probes remained significantly differentially methylated between the intervention and control groups after adjusting for multiple tests. Nevertheless, hierarchical clustering of the top 1000 unadjusted differentially methylated probes revealed two methylation clusters in the intervention study and maternal BMI difference between the two groups (intervention/control) [170]. In the same cohort, they also recently evaluated the epigenetic patterns on saliva samples of 63 infants at 5 years old, following the intervention during pregnancy. Gene pathway analysis identified three functional clusters involved in insulin secretion and resistance for which there were differences between the intervention and control groups [171]. One small clinical trial of 24 women has provided evidence suggesting that maternal dietary GI modifications during pregnancy may affect placental DNA methylation of insulin regulation genes [172]. The UK Pregnancies Better Eating and Activity Trial (UPBEAT) RCT has evaluated the effect of lifestyle intervention (low GI diet plus physical activity) v standard care in 557 pregnant women with obesity. They showed that the methylation changes observed with maternal GDM exposure appeared to be reduced by the pregnancy lifestyle intervention [173]. However, interventional studies on maternal diet during pregnancy as assessed by candidate gene approach remain scarce.

7.2.3. Maternal Under- and Over-Nutrition

Several animal studies have reported that maternal overnutrition or dietary restriction were associated with direct consequences on foetal development. Some investigations conducted in murine models reported that maternal overnutrition programs long-term epigenetic modifications [174,175,176]. A study on maternal high-fat (HF) diet during 4 weeks before and during gestation caused hyperglycaemia and insulinemic resistance in male offspring as well as modification in gene methylation in the offspring liver [174]. In another study, female rats were fed low-fat or HF diet for 6- weeks before pregnancy and during pregnancy. Maternal overnutrition was associated with long-term epigenetic alterations in the offspring’s hypothalamic Proopiomelanocortin (POMC) promoter. The POMC gene is described as a key factor in the control of energy balance [175]. Other results indicate that modest dietary protein restriction during pregnancy may alter the phenotype through epigenetic changes in specific genes [177].
Epidemiological studies conducted in humans have also linked the impact of maternal under- and over-nutrition during critical periods of development with the child development [178]. One of the most significant studies was conducted in children from mothers exposed to the Dutch famine during the periconceptional period and reported a reduced level of methylation of the imprinted gene IGF2 in the adulthood [179]. These results reinforce the periconception period as a crucial period for maintaining epigenetic marks. Recently, in the context of increasing prevalence of childhood obesity, several studies have evaluated the impact of maternal obesity or excessive gestational weight gain on many adverse child outcomes through epigenetic mechanisms. In the Newborn Epigenetics study (NEST) cohort, maternal pre-pregnancy BMI was associated with CpG variations measured in cord blood leukocytes [180]. It has been shown that the methylation differences at CpG sites located in the TAP Binding Protein (TAPBP) gene were associated with BMI z-score and systolic blood pressure (BP) percentile in female and systolic and diastolic BP percentile in male offspring at 5 years [180]. Recent observations from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort identified several CpG sites that are differentially methylated in the cord blood of offspring of obese mothers compared with offspring of normal weight mothers [181]. However, no association between gestational weight gain and DNA methylation has been found [181]. A meta-analysis of 19 cohorts found associations between maternal adiposity and variations in newborn blood DNA methylation [182].

7.2.4. Dietary Quality and Inflammation

While more research concerning maternal obesity and individual micronutrient intake and offspring epigenetics has been conducted, far fewer studies have examined dietary patterns or specific types of maternal diets, which yet reflects dietary quality and food interactions.
The MD pattern has also been associated with higher intake of specific nutrients such as folates that have been shown to influence DNA methylation [183]. However, few studies have evaluated the associations between the MD and epigenetic outcomes. The effects of the MD were assessed in 390 mother–child pairs from the NEST cohort, in nine regions of imprinted genes selected for their involvement in embryonic growth regulation and brain development [183]. They observed a decreased level of methylation at the MEG3-IG DMR in cord blood leukocyte among girls, in response to lower maternal adherence to a MD pattern in early pregnancy [183]. One other publication from the NEST cohort has shown perinatal MD score associations with sex-dependent methylation differences for imprinted control regions of MEG3, IGF2, PLAGL1 and SGCE/PEG10 in cord blood samples [184]. Genomic imprinting is an epigenetic mechanism that leads to the monoallelic expression of genes in a parent-of-origin-dependent manner [185]. Imprinted gene DNA methylation is largely established in the developing gametes and maintained in somatic cells, making it as an important indicator of early exposures [183]. There are few published studies on the relations between the MD and epigenetic outcomes; however. the MD has been largely recommended for its ability to reduce inflammation and improve long-term outcomes in adults [183]. Further research is needed to understand the potential mechanisms.
Inflammation has recently been proposed as another pathway by which maternal diet could affect the epigenome [14]. The hormonal and immunological changes that occur during pregnancy are necessary to support a healthy pregnancy and induce an anti-inflammatory state [186]. Chronic inflammation state during pregnancy, observed in obese women, has been associated with many adverse pregnancy outcomes such as prematurity and LBW [14,87]. Emerging evidence showed the role of chronic inflammation during pregnancy on foetal programming, but the underlying mechanisms are still poorly understood [85]. One study tested the association between the E-DII during pregnancy and both offspring methylation of differentially methylated regions of imprinted gene (n = 338) and circulating cytokines (n = 105) [14]. Although no associations were observed between E-DII and cytokines levels or offspring methylation in infant cord blood, they found that inflammatory cytokine concentrations were associated with lower methylation at the MEG3 imprinted gene [14]. Despite their null findings between maternal E-DII score and DNA methylation, positive associations were reported with birth outcomes suggesting a potential role of inflammatory diet in child development, irrespective of the underlying mechanism. While limited, there is accumulating evidence of an association between maternal inflammatory conditions and offspring methylation.
In summary, it has been largely shown that specific micronutrients are involved in the DNA methylation process; however, further investigations regarding the potential role of maternal dietary quality or inflammation are necessary.

8. Conclusions and Future Directions

8.1. Summary and Discussion of Results

In this review, we examined and summarised findings from a growing body of research investigating associations between maternal dietary inflammatory potential and dietary quality, determined by various scores and foetal development, childhood adiposity, placental measures and epigenetics. The main results suggest that diets of the highest quality, as assessed by the HEI, AHEI, MD, DASH and GI/GL scores, during pregnancy are beneficial for a wide range of maternal and offspring outcomes. However, findings in human studies remain inconsistent.
The evidence regarding DII and E-DII scores highlight the importance of having a less pro-inflammatory diet in pregnant women for improving birth outcomes and reducing the risk of prematurity. The findings in relation to dietary quality associations with long-term child development and placenta development are either conflicting or limited. Finally, few studies investigating relationships between dietary scores and DNA methylation exist. Thus, future research investigating the potential influence of dietary inflammatory status and dietary quality on these outcomes is warranted.
The observed heterogeneity of study populations, ethnicity, differences in dietary assessment methods, timing of dietary assessment and outcome measures may contribute to the observed inconsistent results. Most studies are observational in nature, thus causality cannot be established. However, it has been shown that low-GI dietary intervention may lead to decreased risk of adverse neonatal outcomes [36]. These observations encourage future investigation including RCTs. Finally, another limitation related to nutritional epidemiology is the lack of precision in measuring diet in all its complexity. Although some recent scores like the DII were designed to be comparable across populations [30], information on food consumption was self-reported by women in several studies, which might be subject to recall bias and measurement errors.

8.2. Future Perspectives

Most of the research to date regarding early life nutritional programming has focused on the mother but emerging evidence suggests that paternal nutritional status may also have an effect on child development, independently of maternal diet [24,104]. In a study conducted in Ireland, higher paternal E-DII scores, indicating a more pro-inflammatory diet, were associated with increased risk of childhood OWOB at 5 years [24], whereas higher paternal HEI scores, indicating higher dietary quality, were associated with reduced risk of childhood obesity [104]. Other studies reported that higher paternal BMI at conception was associated with increased offspring BMI [187]. In an American cohort study including 429 father–child pairs, paternal BMI, independently of maternal BMI, was associated with offspring epigenetic modifications at birth and at ages 3 years and 7 years [188]. Moreover, fathers have been described as important contributors of family food practices [189]. Interventions during the pre-conception period should include both parents and consider other family-based health behaviours such as physical activity and sedentary behaviour, which play an important role. Moreover, recent studies showed sex-specific foetal growth patterns associated with maternal healthy lifestyle [100]. This sexual dimorphism might arise from differences in foetal programming and responses to adverse intrauterine exposure. Further research is needed to understand if these may have different implications on long-term health among males and females [190]. Further research to ascertain mechanisms linking maternal diet with health outcomes in offspring is needed. Epigenetic ageing may be a mechanistic link between early-life exposures and risk of adult disease [191]. A recent study reported that a pro-inflammatory, immunological state during pregnancy was associated with shorter offspring telomere length [192]. Telomere biology plays a fundamental role in maintaining genome and cell integrity, and shortened telomere is a well-established indicator of the ageing processes [193]. Further research elucidating such mechanisms is required.
In conclusion, improving our understanding of parental nutritional programming may help inform the development of more effective public health messages, diet and lifestyle interventions and pregnancy guidelines to promote intergenerational health and longevity. Several studies have shown that dietary quality and dietary inflammation state during pregnancy play a role in child development, even if results from some studies remain inconsistent or limited. Strategies aiming to promote adherence to a less pro-inflammatory and better-quality diet across all stages of maternal and childhood life may be of considerable importance to public health.

Author Contributions

All authors contributed to this review: Conceptualization: C.M.P. and M.L.; writing original draft preparation: M.L., S.T. and C.M.P.; manuscript review and editing of final draft: M.L., S.T. and C.M.P. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by an award from the European Union’s Horizon 2020 research and innovation programme under the ERA-Net Cofund of the Joint Programming Initiative Healthy Diet for Healthy Life (JPI-HDHL) (http://www.healthydietforhealthylife.eu accessed on 10 March 2021) action number 696295 (Biomarkers for Nutrition and Health). Co-funding was provided by Science Foundation Ireland, Ireland (Grant Number SFI/16/ERA-HDHL/3360). This work was also supported by an Ad Astra Fellowship and Studentship from University College Dublin, Ireland. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

AAAmino acids
AGAAppropriate for gestational age
AHEIAlternative Healthy Eating Index
AHEI-PAlternate Healthy Eating Index for Pregnancy
ALSPACAvon Longitudinal Study of Parents and Children
aMEDAlternate Mediterranean Diet
BMIBody mass index
BPBlood pressure
CHOCarbohydrate
CVDCardiovascular disease
DASHDietary Approaches to Stop Hypertension
DHADocosahexaenoic acid
DIIDietary inflammatory index
DNBCDanish National Birth Cohort
E-DIIEnergy-adjusted DII
EPAEicosapentaenoic acid
FAFatty acids
FMIFat mass index
FFMIFat-free mass index
FFQsFood frequency questionnaires
FGRFoetal growth restriction
GDMGestational diabetes mellitus
GIGlycaemic Index
GLGlycaemic Load
HEIHealthy Eating Index
HFHigh-fat
IGF2Insulin-like growth factor 2
IIInsulinemic index
ILInsulinemic load
INMAInfancia y Medio Ambiente birth cohort study
IUGRIntrauterine growth retardation
LBWLow birth weight
LGALarge for gestational age
LINE-1Interspersed nuclear element 1
MDMediterranean diet
MDSMD Score
MDScaleMediterranean Diet Scale
MEDLIFEMediterranean Lifestyle
MetSMetabolic syndrome
MFPMediterranean Food Pattern index
NESTNewborn Epigenetics study
NTDNeural tube defects
OCMOne-carbon metabolism
OWOBOverweight and obesity
POMCProopiomelanocortin
PUFAPolyunsaturated fatty acids
RCTsRandomised controlled trials
rMEDRelative Mediterranean diet score
SGASmall for gestational age
TAPBPTAP Binding Protein gene
T2DMType 2 diabetes mellitus
UmPIUmbilical artery pulsatility index
UPBEATUK Pregnancies Better Eating and Activity Trial
USDAUnited States Department of Agriculture.

References

  1. Barker, D.J.P. Mothers, Babies and Health in Later Life; Churchill Livingstone: Edinburgh, UK, 1998. [Google Scholar]
  2. Painter, R.C.; Roseboom, T.J.; Bleker, O.P. Prenatal exposure to the Dutch famine and disease in later life: An overview. Reprod. Toxicol. 2005, 20, 345–352. [Google Scholar] [CrossRef]
  3. Fleming, T.P.; Watkins, A.J.; Velazquez, M.A.; Mathers, J.C.; Prentice, A.M.; Stephenson, J.; Barker, M.; Saffery, R.; Yajnik, C.S.; Eckert, J.J.; et al. Origins of lifetime health around the time of conception: Causes and consequences. Lancet 2018, 391, 1842–1852. [Google Scholar] [CrossRef]
  4. Barker, D.J.; Gluckman, P.D.; Godfrey, K.M.; Harding, J.E.; Owens, J.A.; Robinson, J.S. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341, 938–941. [Google Scholar] [CrossRef]
  5. Gluckman, P.D.; Hanson, M.A.; Cooper, C.; Thornburg, K.L. Effect of In Utero and Early-Life Conditions on Adult Health and Disease. N. Engl. J. Med. 2008, 359, 61–73. [Google Scholar] [CrossRef] [Green Version]
  6. Barker, D.J.; Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1, 1077–1081. [Google Scholar] [CrossRef]
  7. Hales, C.N.; Barker, D.J. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992, 35, 595–601. [Google Scholar] [CrossRef]
  8. Osmond, C.; Barker, D.J.; Winter, P.D.; Fall, C.H.; Simmonds, S.J. Early growth and death from cardiovascular disease in women. BMJ 1993, 307, 1519–1524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Dabelea, D.; Mayer-Davis, E.J.; Lamichhane, A.P.; D’Agostino, R.B.; Liese, A.D.; Vehik, K.S.; Narayan, K.M.V.; Zeitler, P.; Hamman, R.F. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: The SEARCH Case-Control Study. Diabetes Care 2008, 31, 1422–1426. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. McMillen, I.C.; MacLaughlin, S.M.; Muhlhausler, B.S.; Gentili, S.; Duffield, J.L.; Morrison, J.L. Developmental origins of adult health and disease: The role of periconceptional and foetal nutrition. Basic Clin. Pharmacol. Toxicol. 2008, 102, 82–89. [Google Scholar] [CrossRef]
  11. Michels, K.B.; Schulze, M.B. Can dietary patterns help us detect diet-disease associations? Nutr. Res. Rev. 2005, 18, 241–248. [Google Scholar] [CrossRef]
  12. Wirt, A.; Collins, C.E. Diet quality--what is it and does it matter? Public Health Nutr. 2009, 12, 2473–2492. [Google Scholar] [CrossRef] [Green Version]
  13. Doyle, I.M.; Borrmann, B.; Grosser, A.; Razum, O.; Spallek, J. Determinants of dietary patterns and diet quality during pregnancy: A systematic review with narrative synthesis. Public Health Nutr. 2017, 20, 1009–1028. [Google Scholar] [CrossRef] [PubMed]
  14. McCullough, L.E.; Miller, E.E.; Calderwood, L.E.; Shivappa, N.; Steck, S.E.; Forman, M.R.; Mendez, M.A.; Maguire, R.; Fuemmeler, B.F.; Kollins, S.H.; et al. Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators? Epigenetics 2017, 12, 688–697. [Google Scholar] [CrossRef] [PubMed]
  15. Sen, S.; Rifas-Shiman, S.L.; Shivappa, N.; Wirth, M.D.; Hébert, J.R.; Gold, D.R.; Gillman, M.W.; Oken, E. Dietary Inflammatory Potential during Pregnancy Is Associated with Lower Fetal Growth and Breastfeeding Failure: Results from Project Viva. J. Nutr. 2016, 146, 728–736. [Google Scholar] [CrossRef]
  16. Jansson, T.; Powell, T.L. Role of the placenta in fetal programming: Underlying mechanisms and potential interventional approaches. Clin. Sci. 2007, 113, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Belkacemi, L.; Nelson, D.M.; Desai, M.; Ross, M.G. Maternal Undernutrition Influences Placental-Fetal Development. Biol. Reprod. 2010, 83, 325–331. [Google Scholar] [CrossRef] [Green Version]
  18. Dominguez-Salas, P.; Cox, S.E.; Prentice, A.M.; Hennig, B.J.; Moore, S.E. Maternal nutritional status, C(1) metabolism and offspring DNA methylation: A review of current evidence in human subjects. Proc. Nutr. Soc. 2012, 71, 154–165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Anderson, O.S.; Sant, K.E.; Dolinoy, D.C. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism, and DNA methylation. J. Nutr. Biochem. 2012, 23, 853–859. [Google Scholar] [CrossRef] [Green Version]
  20. Monthé-Drèze, C.; Rifas-Shiman, S.L.; Aris, I.M.; Shivappa, N.; Hebert, J.R.; Sen, S.; Oken, E. Maternal diet in pregnancy is associated with differences in child body mass index trajectories from birth to adolescence. Am. J. Clin. Nutr. 2021. [Google Scholar] [CrossRef]
  21. Mousa, A.; Naqash, A.; Lim, S. Macronutrient and Micronutrient Intake during Pregnancy: An Overview of Recent Evidence. Nutrients 2019, 11, 443. [Google Scholar] [CrossRef] [Green Version]
  22. Oh, C.; Keats, E.C.; Bhutta, Z.A. Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Nutrients 2020, 12, 491. [Google Scholar] [CrossRef] [Green Version]
  23. Gleason, P.M.; Boushey, C.J.; Harris, J.E.; Zoellner, J. Publishing nutrition research: A review of multivariate techniques--part 3: Data reduction methods. J. Acad. Nutr. Diet. 2015, 115, 1072–1082. [Google Scholar] [CrossRef]
  24. Navarro, P.; Shivappa, N.; Hébert, J.R.; Mehegan, J.; Murrin, C.M.; Kelleher, C.C.; Phillips, C.M. Intergenerational associations of dietary inflammatory index with birth outcomes and weight status at age 5 and 9: Results from the Lifeways cross-generation cohort study. Pediatr. Obes. 2020, 15, e12588. [Google Scholar] [CrossRef] [PubMed]
  25. Phillips, C.M.; Chen, L.W.; Heude, B.; Bernard, J.Y.; Harvey, N.C.; Duijts, L.; Mensink-Bout, S.M.; Polanska, K.; Mancano, G.; Suderman, M.; et al. Dietary Inflammatory Index and Non-Communicable Disease Risk: A Narrative Review. Nutrients 2019, 11, 1873. [Google Scholar] [CrossRef] [Green Version]
  26. Soltani, S.; Arablou, T.; Jayedi, A.; Salehi-Abargouei, A. Adherence to the dietary approaches to stop hypertension (DASH) diet in relation to all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of prospective cohort studies. Nutr. J. 2020, 19, 37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Morze, J.; Danielewicz, A.; Hoffmann, G.; Schwingshackl, L. Diet Quality as Assessed by the Healthy Eating Index, Alternate Healthy Eating Index, Dietary Approaches to Stop Hypertension Score, and Health Outcomes: A Second Update of a Systematic Review and Meta-Analysis of Cohort Studies. J. Acad. Nutr. Diet. 2020, 120, 1998–2031.e1915. [Google Scholar] [CrossRef] [PubMed]
  28. Aljuraiban, G.S.; Gibson, R.; Oude Griep, L.M.; Okuda, N.; Steffen, L.M.; Van Horn, L.; Chan, Q. Perspective: The Application of A Priori Diet Quality ScoRes. to Cardiovascular Disease Risk—A Critical Evaluation of Current Scoring Systems. Adv. Nutr. 2020, 11, 10–24. [Google Scholar] [CrossRef] [PubMed]
  29. Shivappa, N.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Hébert, J.R. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014, 17, 1689–1696. [Google Scholar] [CrossRef] [Green Version]
  30. Hébert, J.R.; Shivappa, N.; Wirth, M.D.; Hussey, J.R.; Hurley, T.G. Perspective: The Dietary Inflammatory Index (DII)-Lessons Learned, Improvements Made, and Future Directions. Adv. Nutr. 2019, 10, 185–195. [Google Scholar] [CrossRef] [PubMed]
  31. Cavicchia, P.P.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Ma, Y.; Ockene, I.S.; Hébert, J.R. A New Dietary Inflammatory Index Predicts Interval Changes in Serum High-Sensitivity C-Reactive Protein. J. Nutr. 2009, 139, 2365–2372. [Google Scholar] [CrossRef]
  32. World Health Organisation. Macronutrients. Available online: http://www.emro.who.int/health-topics/macronutrients/index.html (accessed on 2 June 2021).
  33. Fogelholm, M.; Anderssen, S.; Gunnarsdottir, I.; Lahti-Koski, M. Dietary macronutrients and food consumption as determinants of long-term weight change in adult populations: A systematic literature review. Food Nutr. Res. 2012, 56, 19103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Brion, M.-J.A.; Ness, A.R.; Rogers, I.; Emmett, P.; Cribb, V.; Davey Smith, G.; Lawlor, D.A. Maternal macronutrient and energy intakes in pregnancy and offspring intake at 10 y: Exploring parental comparisons and prenatal effects. Am. J. Clin. Nutr. 2010, 91, 748–756. [Google Scholar] [CrossRef] [Green Version]
  35. Wahab, R.J.; Scholing, J.M.; Gaillard, R. Maternal early pregnancy dietary glycemic index and load, fetal growth, and the risk of adverse birth outcomes. Eur. J. Nutr. 2020. [Google Scholar] [CrossRef] [PubMed]
  36. Zhang, R.; Han, S.; Chen, G.C.; Li, Z.N.; Silva-Zolezzi, I.; Parés, G.V.; Wang, Y.; Qin, L.Q. Effects of low-glycemic-index diets in pregnancy on maternal and newborn outcomes in pregnant women: A meta-analysis of randomized controlled trials. Eur. J. Nutr. 2018, 57, 167–177. [Google Scholar] [CrossRef] [PubMed]
  37. Jenkins, D.J.; Wolever, T.M.; Taylor, R.H.; Barker, H.; Fielden, H.; Baldwin, J.M.; Bowling, A.C.; Newman, H.C.; Jenkins, A.L.; Goff, D.V. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am. J. Clin. Nutr. 1981, 34, 362–366. [Google Scholar] [CrossRef] [Green Version]
  38. Chen, L.W.; Navarro, P.; Murrin, C.M.; Mehegan, J.; Kelleher, C.C.; Phillips, C.M. Maternal Dietary Glycemic and Insulinemic Indexes Are Not Associated with Birth Outcomes or Childhood Adiposity at 5 Years of Age in an Irish Cohort Study. J. Nutr. 2019, 149, 1037–1046. [Google Scholar] [CrossRef]
  39. Jayedi, A.; Soltani, S.; Jenkins, D.; Sievenpiper, J.; Shab-Bidar, S. Dietary glycemic index, glycemic load, and chronic disease: An umbrella review of meta-analyses of prospective cohort studies. Crit. Rev. Food Sci. Nutr. 2020, 60. [Google Scholar] [CrossRef]
  40. Gomes, C.B.; Malta, M.B.; Antunes, J.L.F.; Gallo, C.O.; Benício, M.H.D.; Carvalhaes, M. The association of dietary glycaemic index and glycaemic load with gestational weight gain and newborn birth weight. Br. J. Nutr. 2020, 123, 818–825. [Google Scholar] [CrossRef]
  41. Cetin, I.; Bühling, K.; Demir, C.; Kortam, A.; Prescott, S.L.; Yamashiro, Y.; Yarmolinskaya, M.; Koletzko, B. Impact of Micronutrient Status during Pregnancy on Early Nutrition Programming. Ann. Nutr. Metab. 2019, 74, 269–278. [Google Scholar] [CrossRef] [PubMed]
  42. World Health Organisation. Micronutrients. Available online: https://www.who.int/health-topics/micronutrients#tab=tab_1 (accessed on 2 June 2021).
  43. Miller, V.; Webb, P.; Micha, R.; Mozaffarian, D. Defining diet quality: A synthesis of dietary quality metrics and their validity for the double burden of malnutrition. Lancet Planet. Health 2020, 4, e352–e370. [Google Scholar] [CrossRef]
  44. Diemert, A.; Lezius, S.; Pagenkemper, M.; Hansen, G.; Drozdowska, A.; Hecher, K.; Arck, P.; Zyriax, B.C. Maternal nutrition, inadequate gestational weight gain and birth weight: Results from a prospective birth cohort. BMC Pregnancy Childbirth 2016, 16, 224. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Horan, M.K.; McGowan, C.A.; Gibney, E.R.; Donnelly, J.M.; McAuliffe, F.M. The association between maternal dietary micronutrient intake and neonatal anthropometry—secondary analysis from the ROLO study. Nutr. J. 2015, 14, 105. [Google Scholar] [CrossRef] [PubMed]
  46. Lazarus, J.H. Iodine status in europe in 2014. Eur. Thyroid J. 2014, 3, 3–6. [Google Scholar] [CrossRef] [Green Version]
  47. Williams, P.J.; Bulmer, J.N.; Innes, B.A.; Broughton Pipkin, F. Possible Roles for Folic Acid in the Regulation of Trophoblast Invasion and Placental Development in Normal Early Human Pregnancy. Biol. Reprod. 2011, 84, 1148–1153. [Google Scholar] [CrossRef]
  48. McGee, M.; Bainbridge, S.; Fontaine-Bisson, B. A crucial role for maternal dietary methyl donor intake in epigenetic programming and fetal growth outcomes. Nutr. Rev. 2018, 76, 469–478. [Google Scholar] [CrossRef]
  49. Caffrey, A.; McNulty, H.; Irwin, R.E.; Walsh, C.P.; Pentieva, K. Maternal folate nutrition and offspring health: Evidence and current controversies. Proc. Nutr. Soc. 2019, 78, 208–220. [Google Scholar] [CrossRef]
  50. Morse, N.L. Benefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactation. Nutrients 2012, 4, 799–840. [Google Scholar] [CrossRef] [Green Version]
  51. De-Regil, L.M.; Peña-Rosas, J.P.; Fernández-Gaxiola, A.C.; Rayco-Solon, P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst. Rev. 2015, Cd007950. [Google Scholar] [CrossRef] [PubMed]
  52. Yajnik, C.S.; Deshmukh, U.S. Fetal programming: Maternal nutrition and role of one-carbon metabolism. Rev. Endocr. Metab. Disord. 2012, 13, 121–127. [Google Scholar] [CrossRef] [PubMed]
  53. Yajnik, C.S.; Deshpande, S.S.; Jackson, A.A.; Refsum, H.; Rao, S.; Fisher, D.J.; Bhat, D.S.; Naik, S.S.; Coyaji, K.J.; Joglekar, C.V.; et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: The Pune Maternal Nutrition Study. Diabetologia 2008, 51, 29–38. [Google Scholar] [CrossRef] [Green Version]
  54. Aoun, C.; Papazian, T.; Helou, K.; El Osta, N.; Khabbaz, L.R. Comparison of five international indices of adherence to the Mediterranean diet among healthy adults: Similarities and differences. Nutr. Res. Pract. 2019, 13, 333–343. [Google Scholar] [CrossRef]
  55. Zaragoza-Martí, A.; Cabañero-Martínez, M.J.; Hurtado-Sánchez, J.A.; Laguna-Pérez, A.; Ferrer-Cascales, R. Evaluation of Mediterranean diet adherence scores: A systematic review. BMJ. Open 2018, 8, e019033. [Google Scholar] [CrossRef] [Green Version]
  56. Guenther, P.M.; Casavale, K.O.; Reedy, J.; Kirkpatrick, S.I.; Hiza, H.A.; Kuczynski, K.J.; Kahle, L.L.; Krebs-Smith, S.M. Update of the Healthy Eating Index: HEI-2010. J. Acad. Nutr. Diet. 2013, 113, 569–580. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Krebs-Smith, S.M.; Pannucci, T.E.; Subar, A.F.; Kirkpatrick, S.I.; Lerman, J.L.; Tooze, J.A.; Wilson, M.M.; Reedy, J. Update of the Healthy Eating Index: HEI-2015. J. Acad Nutr. Diet 2018, 118, 1591–1602. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Al-Ibrahim, A.A.; Jackson, R.T. Healthy eating index versus alternate healthy index in relation to diabetes status and health markers in U.S. adults: NHANES 2007–2010. Nutr. J. 2019, 18, 26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Schwingshackl, L.; Bogensberger, B.; Hoffmann, G. Diet Quality as Assessed by the Healthy Eating Index, Alternate Healthy Eating Index, Dietary Approaches to Stop Hypertension Score, and Health Outcomes: An Updated Systematic Review and Meta-Analysis of Cohort Studies. J. Acad. Nutr. Diet. 2018, 118, 74–100.e111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Fung, T.T.; Chiuve, S.E.; McCullough, M.L.; Rexrode, K.M.; Logroscino, G.; Hu, F.B. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 2008, 168, 713–720. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Sacks, F.M.; Obarzanek, E.; Windhauser, M.M.; Svetkey, L.P.; Vollmer, W.M.; McCullough, M.; Karanja, N.; Lin, P.H.; Steele, P.; Proschan, M.A.; et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann. Epidemiol. 1995, 5, 108–118. [Google Scholar] [CrossRef]
  62. Venn, B.J.; Green, T.J. Glycemic index and glycemic load: Measurement issues and their effect on diet–disease relationships. Eur. J. Clin. Nutr. 2007, 61, S122–S131. [Google Scholar] [CrossRef]
  63. Martínez-González, M.A.; Gea, A.; Ruiz-Canela, M. The Mediterranean Diet and Cardiovascular Health. Circ. Res. 2019, 124, 779–798. [Google Scholar] [CrossRef]
  64. Guenther, P.M.; Kirkpatrick, S.I.; Reedy, J.; Krebs-Smith, S.M.; Buckman, D.W.; Dodd, K.W.; Casavale, K.O.; Carroll, R.J. The Healthy Eating Index-2010 is a valid and reliable measure of diet quality according to the 2010 Dietary Guidelines for Americans. J. Nutr. 2014, 144, 399–407. [Google Scholar] [CrossRef] [Green Version]
  65. Chiuve, S.E.; Fung, T.T.; Rimm, E.B.; Hu, F.B.; McCullough, M.L.; Wang, M.; Stampfer, M.J.; Willett, W.C. Alternative dietary indices both strongly predict risk of chronic disease. J. Nutr. 2012, 142, 1009–1018. [Google Scholar] [CrossRef] [Green Version]
  66. Brauer, P.; Royall, D.; Rodrigues, A. Use of the Healthy Eating Index in Intervention Studies for Cardiometabolic Risk Conditions: A Systematic Review. Adv. Nutr. 2021. [Google Scholar] [CrossRef] [PubMed]
  67. Murrin, C.; Shrivastava, A.; Kelleher, C.C.; Lifeways Cross-generation Cohort Study Steering Group. Maternal macronutrient intake during pregnancy and 5 years postpartum and associations with child weight status aged five. Eur. J. Clin. Nutr. 2013, 67, 670–679. [Google Scholar] [CrossRef] [Green Version]
  68. Chia, A.-R.; Chen, L.-W.; Lai, J.S.; Wong, C.H.; Neelakantan, N.; van Dam, R.M.; Chong, M.F.-F. Maternal Dietary Patterns and Birth Outcomes: A Systematic Review and Meta-Analysis. Adv. Nutr. 2019, 10, 685–695. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Aubert, A.M.; Forhan, A.; de Lauzon-Guillain, B.; Chen, L.W.; Polanska, K.; Hanke, W.; Jankowska, A.; Mensink-Bout, S.M.; Duijts, L.; Suderman, M.; et al. Deriving the Dietary Approaches to Stop Hypertension (DASH) Score in Women from Seven Pregnancy Cohorts from the European ALPHABET Consortium. Nutrients 2019, 11, 2706. [Google Scholar] [CrossRef] [Green Version]
  70. Eckl, M.R.; Brouwer-Brolsma, E.M.; Küpers, L.K. Maternal Adherence to the Mediterranean Diet during Pregnancy: A Review of Commonly Used a priori Indexes. Nutrients 2021, 13, 582. [Google Scholar] [CrossRef] [PubMed]
  71. Trichopoulou, A.; Costacou, T.; Bamia, C.; Trichopoulos, D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 2003, 348, 2599–2608. [Google Scholar] [CrossRef] [Green Version]
  72. Serra-Majem, L.; Ribas, L.; Ngo, J.; Ortega, R.M.; García, A.; Pérez-Rodrigo, C.; Aranceta, J. Food, youth and the Mediterranean diet in Spain. Development of KIDMED, Mediterranean Diet Quality Index in children and adolescents. Public Health Nutr. 2004, 7, 931–935. [Google Scholar] [CrossRef] [PubMed]
  73. Haugen, M.; Meltzer, H.M.; Brantsaeter, A.L.; Mikkelsen, T.; Osterdal, M.L.; Alexander, J.; Olsen, S.F.; Bakketeig, L. Mediterranean-type diet and risk of preterm birth among women in the Norwegian Mother and Child Cohort Study (MoBa): A prospective cohort study. Acta Obstet. Gynecol. Scand. 2008, 87, 319–324. [Google Scholar] [CrossRef] [PubMed]
  74. Khoury, J.; Henriksen, T.; Christophersen, B.; Tonstad, S. Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: A randomized clinical trial. Am. J. Obstet. Gynecol. 2005, 193, 1292–1301. [Google Scholar] [CrossRef] [PubMed]
  75. Rifas-Shiman, S.L.; Rich-Edwards, J.W.; Kleinman, K.P.; Oken, E.; Gillman, M.W. Dietary quality during pregnancy varies by maternal characteristics in Project Viva: A US cohort. J. Am. Diet. Assoc. 2009, 109, 1004–1011. [Google Scholar] [CrossRef] [Green Version]
  76. Han, C.Y.; Colega, M.; Quah, E.P.L.; Chan, Y.H.; Godfrey, K.M.; Kwek, K.; Saw, S.-M.; Gluckman, P.D.; Chong, Y.-S.; Chong, M.F.-F.; et al. A healthy eating index to measure diet quality in pregnant women in Singapore: A cross-sectional study. BMC Nutr. 2015, 1, 39. [Google Scholar] [CrossRef] [Green Version]
  77. Asemi, Z.; Tabassi, Z.; Samimi, M.; Fahiminejad, T.; Esmaillzadeh, A. Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: A randomised clinical trial. Br. J. Nutr. 2013, 109, 2024–2030. [Google Scholar] [CrossRef] [PubMed]
  78. Asemi, Z.; Samimi, M.; Tabassi, Z.; Esmaillzadeh, A. The effect of DASH diet on pregnancy outcomes in gestational diabetes: A randomized controlled clinical trial. Eur. J. Clin. Nutr. 2014, 68, 490–495. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Courtney, A.U.; O’Brien, E.C.; Crowley, R.K.; Geraghty, A.A.; Brady, M.B.; Kilbane, M.T.; Twomey, P.J.; McKenna, M.J.; McAuliffe, F.M. DASH (Dietary Approaches to Stop Hypertension) dietary pattern and maternal blood pressure in pregnancy. J. Hum. Nutr. Diet. 2020, 33, 686–697. [Google Scholar] [CrossRef] [PubMed]
  80. Amati, F.; Hassounah, S.; Swaka, A. The Impact of Mediterranean Dietary Patterns During Pregnancy on Maternal and Offspring Health. Nutrients 2019, 11, 1098. [Google Scholar] [CrossRef] [Green Version]
  81. Walsh, J.M.; McGowan, C.A.; Mahony, R.; Foley, M.E.; McAuliffe, F.M. Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): Randomised control trial. BMJ. 2012, 345, e5605. [Google Scholar] [CrossRef] [Green Version]
  82. Jiang, F.; Li, Y.; Xu, P.; Li, J.; Chen, X.; Yu, H.; Gao, B.; Xu, B.; Li, X.; Chen, W. The efficacy of the Dietary Approaches to Stop Hypertension diet with respect to improving pregnancy outcomes in women with hypertensive disorders. J. Hum. Nutr. Diet. 2019, 32, 713–718. [Google Scholar] [CrossRef]
  83. Knudsen, V.K.; Heitmann, B.L.; Halldorsson, T.I.; Sørensen, T.I.; Olsen, S.F. Maternal dietary glycaemic load during pregnancy and gestational weight gain, birth weight and postpartum weight retention: A study within the Danish National Birth Cohort. Br. J. Nutr. 2013, 109, 1471–1478. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Sen, S.; Rifas-Shiman, S.L.; Shivappa, N.; Wirth, M.D.; Hebert, J.R.; Gold, D.R.; Gillman, M.W.; Oken, E. Associations of prenatal and early life dietary inflammatory potential with childhood adiposity and cardiometabolic risk in Project Viva. Pediatr. Obes. 2018, 13, 292–300. [Google Scholar] [CrossRef] [PubMed]
  85. Segovia, S.A.; Vickers, M.H.; Gray, C.; Reynolds, C.M. Maternal obesity, inflammation, and developmental programming. BioMed. Res. Int. 2014, 2014, 418975. [Google Scholar] [CrossRef] [PubMed]
  86. Moore, B.F.; Sauder, K.A.; Starling, A.P.; Hébert, J.R.; Shivappa, N.; Ringham, B.M.; Glueck, D.H.; Dabelea, D. Proinflammatory Diets during Pregnancy and Neonatal Adiposity in the Healthy Start Study. J. Pediatr. 2018, 195, 121–127.e122. [Google Scholar] [CrossRef]
  87. Chen, L.W.; Aubert, A.M.; Shivappa, N.; Bernard, J.Y.; Mensink-Bout, S.M.; Geraghty, A.A.; Mehegan, J.; Suderman, M.; Polanska, K.; Hanke, W.; et al. Associations of maternal dietary inflammatory potential and quality with offspring birth outcomes: An individual participant data pooled analysis of 7 European cohorts in the ALPHABET consortium. PLoS Med. 2021, 18, e1003491. [Google Scholar] [CrossRef]
  88. Timmermans, S.; Steegers-Theunissen, R.P.; Vujkovic, M.; den Breeijen, H.; Russcher, H.; Lindemans, J.; Mackenbach, J.; Hofman, A.; Lesaffre, E.E.; Jaddoe, V.V.; et al. The Mediterranean diet and fetal size parameters: The Generation R Study. Br. J. Nutr. 2012, 108, 1399–1409. [Google Scholar] [CrossRef] [Green Version]
  89. Chatzi, L.; Mendez, M.; Garcia, R.; Roumeliotaki, T.; Ibarluzea, J.; Tardón, A.; Amiano, P.; Lertxundi, A.; Iñiguez, C.; Vioque, J.; et al. Mediterranean diet adherence during pregnancy and fetal growth: INMA (Spain) and RHEA (Greece) mother-child cohort studies. Br. J. Nutr. 2012, 107, 135–145. [Google Scholar] [CrossRef]
  90. Saunders, L.; Guldner, L.; Costet, N.; Kadhel, P.; Rouget, F.; Monfort, C.; Thomé, J.P.; Multigner, L.; Cordier, S. Effect of a Mediterranean diet during pregnancy on fetal growth and preterm delivery: Results from a French Caribbean Mother-Child Cohort Study (TIMOUN). Paediatr. Perinat. Epidemiol. 2014, 28, 235–244. [Google Scholar] [CrossRef] [Green Version]
  91. Mikkelsen, T.B.; Osterdal, M.L.; Knudsen, V.K.; Haugen, M.; Meltzer, H.M.; Bakketeig, L.; Olsen, S.F. Association between a Mediterranean-type diet and risk of preterm birth among Danish women: A prospective cohort study. Acta Obstet. Gynecol. Scand. 2008, 87, 325–330. [Google Scholar] [CrossRef]
  92. Yisahak, S.F.; Mumford, S.L.; Grewal, J.; Li, M.; Zhang, C.; Grantz, K.L.; Hinkle, S.N. Maternal diet patterns during early pregnancy in relation to neonatal outcomes. Am. J. Clin. Nutr. 2021. [Google Scholar] [CrossRef] [PubMed]
  93. Peraita-Costa, I.; Llopis-González, A.; Perales-Marín, A.; Diago, V.; Soriano, J.M.; Llopis-Morales, A.; Morales-Suárez-Varela, M. Maternal profile according to Mediterranean diet adherence and small for gestational age and preterm newborn outcomes. Public Health Nutr. 2020, 24, 1372–1384. [Google Scholar] [CrossRef]
  94. Martínez-Galiano, J.M.; Olmedo-Requena, R.; Barrios-Rodríguez, R.; Amezcua-Prieto, C.; Bueno-Cavanillas, A.; Salcedo-Bellido, I.; Jimenez-Moleon, J.J.; Delgado-Rodríguez, M. Effect of Adherence to a Mediterranean Diet and Olive Oil Intake during Pregnancy on Risk of Small for Gestational Age Infants. Nutrients 2018, 10, 1234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Martínez-González, M.A.; Fernández-Jarne, E.; Serrano-Martínez, M.; Wright, M.; Gomez-Gracia, E. Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Eur. J. Clin. Nutr. 2004, 58, 1550–1552. [Google Scholar] [CrossRef] [Green Version]
  96. Panagiotakos, D.B.; Pitsavos, C.; Arvaniti, F.; Stefanadis, C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev. Med. 2007, 44, 335–340. [Google Scholar] [CrossRef] [PubMed]
  97. Gómez Roig, M.D.; Mazarico, E.; Ferrero, S.; Montejo, R.; Ibáñez, L.; Grima, F.; Vela, A. Differences in dietary and lifestyle habits between pregnant women with small fetuses and appropriate-for-gestational-age fetuses. J. Obstet. Gynaecol. Res. 2017, 43, 1145–1151. [Google Scholar] [CrossRef]
  98. Biagi, C.; Nunzio, M.D.; Bordoni, A.; Gori, D.; Lanari, M. Effect of Adherence to Mediterranean Diet during Pregnancy on Children’s Health: A Systematic Review. Nutrients 2019, 11, 997. [Google Scholar] [CrossRef] [Green Version]
  99. Rodríguez-Bernal, C.L.; Rebagliato, M.; Iñiguez, C.; Vioque, J.; Navarrete-Muñoz, E.M.; Murcia, M.; Bolumar, F.; Marco, A.; Ballester, F. Diet quality in early pregnancy and its effects on fetal growth outcomes: The Infancia y Medio Ambiente (Childhood and Environment) Mother and Child Cohort Study in Spain. Am. J. Clin. Nutr. 2010, 91, 1659–1666. [Google Scholar] [CrossRef] [Green Version]
  100. Badon, S.E.; Miller, R.S.; Qiu, C.; Sorensen, T.K.; Williams, M.A.; Enquobahrie, D.A. Maternal healthy lifestyle during early pregnancy and offspring birthweight: Differences by offspring sex. J. Matern. Fetal Neonatal. Med. 2018, 31, 1111–1117. [Google Scholar] [CrossRef]
  101. Poon, A.K.; Yeung, E.; Boghossian, N.; Albert, P.S.; Zhang, C. Maternal Dietary Patterns during Third Trimester in Association with Birthweight Characteristics and Early Infant Growth. Science 2013, 2013, 786409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Shapiro, A.L.; Kaar, J.L.; Crume, T.L.; Starling, A.P.; Siega-Riz, A.M.; Ringham, B.M.; Glueck, D.H.; Norris, J.M.; Barbour, L.A.; Friedman, J.E.; et al. Maternal diet quality in pregnancy and neonatal adiposity: The Healthy Start Study. Int. J. Obes. 2016, 40, 1056–1062. [Google Scholar] [CrossRef] [Green Version]
  103. Zhu, Y.; Hedderson, M.M.; Sridhar, S.; Xu, F.; Feng, J.; Ferrara, A. Poor diet quality in pregnancy is associated with increased risk of excess fetal growth: A prospective multi-racial/ethnic cohort study. Int. J. Epidemiol. 2019, 48, 423–432. [Google Scholar] [CrossRef]
  104. Navarro, P.; Mehegan, J.; Murrin, C.M.; Kelleher, C.C.; Phillips, C.M. Adherence to the Healthy Eating Index-2015 across Generations Is Associated with Birth Outcomes and Weight Status at Age 5 in the Lifeways Cross-Generation Cohort Study. Nutrients 2019, 11, 928. [Google Scholar] [CrossRef] [Green Version]
  105. Chia, A.R.; Tint, M.T.; Han, C.Y.; Chen, L.W.; Colega, M.; Aris, I.M.; Chua, M.C.; Tan, K.H.; Yap, F.; Shek, L.P.; et al. Adherence to a healthy eating index for pregnant women is associated with lower neonatal adiposity in a multiethnic Asian cohort: The Growing Up in Singapore Towards healthy Outcomes (GUSTO) Study. Am. J. Clin. Nutr. 2018, 107, 71–79. [Google Scholar] [CrossRef]
  106. McCullough, M.L.; Feskanich, D.; Stampfer, M.J.; Giovannucci, E.L.; Rimm, E.B.; Hu, F.B.; Spiegelman, D.; Hunter, D.J.; Colditz, G.A.; Willett, W.C. Diet quality and major chronic disease risk in men and women: Moving toward improved dietary guidance. Am. J. Clin. Nutr. 2002, 76, 1261–1271. [Google Scholar] [CrossRef] [Green Version]
  107. Li, S.; Gan, Y.; Chen, M.; Wang, M.; Wang, X.; Santos, H.O.; Okunade, K.; Kathirgamathamby, V. Effects of the Dietary Approaches to Stop Hypertension (DASH) on Pregnancy/Neonatal Outcomes and Maternal Glycemic Control: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Complementary Ther. Med. 2020, 54, 102551. [Google Scholar] [CrossRef]
  108. Vesco, K.K.; Karanja, N.; King, J.C.; Gillman, M.W.; Leo, M.C.; Perrin, N.; McEvoy, C.T.; Eckhardt, C.L.; Smith, K.S.; Stevens, V.J. Efficacy of a group-based dietary intervention for limiting gestational weight gain among obese women: A randomized trial. Obesity 2014, 22, 1989–1996. [Google Scholar] [CrossRef]
  109. Van Horn, L.; Peaceman, A.; Kwasny, M.; Vincent, E.; Fought, A.; Josefson, J.; Spring, B.; Neff, L.M.; Gernhofer, N. Dietary Approaches to Stop Hypertension Diet and Activity to Limit Gestational Weight: Maternal Offspring Metabolics Family Intervention Trial, a Technology Enhanced Randomized Trial. Am. J. Prev. Med. 2018, 55, 603–614. [Google Scholar] [CrossRef] [PubMed]
  110. Fulay, A.P.; Rifas-Shiman, S.L.; Oken, E.; Perng, W. Associations of the dietary approaches to stop hypertension (DASH) diet with pregnancy complications in Project Viva. Eur. J. Clin. Nutr. 2018, 72, 1385–1395. [Google Scholar] [CrossRef] [PubMed]
  111. Martin, C.L.; Sotres-Alvarez, D.; Siega-Riz, A.M. Maternal Dietary Patterns during the Second Trimester Are Associated with Preterm Birth. J. Nutr. 2015, 145, 1857–1864. [Google Scholar] [CrossRef] [PubMed]
  112. Perichart-Perera, O.; Balas-Nakash, M.; Rodríguez-Cano, A.; Legorreta-Legorreta, J.; Parra-Covarrubias, A.; Vadillo-Ortega, F. Low Glycemic Index Carbohydrates versus All Types of Carbohydrates for Treating Diabetes in Pregnancy: A Randomized Clinical Trial to Evaluate the Effect of Glycemic Control. Int. J. Endocrinol. 2012, 2012, 296017. [Google Scholar] [CrossRef] [PubMed]
  113. Horan, M.K.; McGowan, C.A.; Gibney, E.R.; Byrne, J.; Donnelly, J.M.; McAuliffe, F.M. Maternal Nutrition and Glycaemic Index during Pregnancy Impacts on Offspring Adiposity at 6 Months of Age—Analysis from the ROLO Randomised Controlled Trial. Nutrients 2016, 8, 7. [Google Scholar] [CrossRef] [Green Version]
  114. Moses, R.G.; Casey, S.A.; Quinn, E.G.; Cleary, J.M.; Tapsell, L.C.; Milosavljevic, M.; Petocz, P.; Brand-Miller, J.C. Pregnancy and Glycemic Index Outcomes study: Effects of low glycemic index compared with conventional dietary advice on selected pregnancy outcomes. Am. J. Clin. Nutr. 2014, 99, 517–523. [Google Scholar] [CrossRef] [Green Version]
  115. Callanan, S.; Yelverton, C.A.; Geraghty, A.A.; O’Brien, E.C.; Donnelly, J.M.; Larkin, E.; Horan, M.K.; Mehegan, J.; McAuliffe, F.M. The association of a low glycaemic index diet in pregnancy with child body composition at 5 years of age: A secondary analysis of the ROLO study. Pediatric Obes. 2021, e12820. [Google Scholar] [CrossRef]
  116. Strohmaier, S.; Bogl, L.H.; Eliassen, A.H.; Massa, J.; Field, A.E.; Chavarro, J.E.; Ding, M.; Tamimi, R.M.; Schernhammer, E. Maternal healthful dietary patterns during peripregnancy and long-term overweight risk in their offspring. Eur. J. Epidemiol. 2020, 35, 283–293. [Google Scholar] [CrossRef] [Green Version]
  117. Maslova, E.; Hansen, S.; Grunnet, L.G.; Strøm, M.; Bjerregaard, A.A.; Hjort, L.; Kampmann, F.B.; Madsen, C.M.; Thuesen, A.C.B.; Bech, B.H.; et al. Maternal glycemic index and glycemic load in pregnancy and offspring metabolic health in childhood and adolescence—A cohort study of 68,471 mother–offspring dyads from the Danish National Birth Cohort. Eur. J. Clin. Nutr. 2019, 73, 1049–1062. [Google Scholar] [CrossRef]
  118. Gonzalez-Nahm, S.; Hoyo, C.; Østbye, T.; Neelon, B.; Allen, C.; Benjamin-Neelon, S.E. Associations of maternal diet with infant adiposity at birth, 6 months and 12 months. BMJ Open 2019, 9, e030186. [Google Scholar] [CrossRef] [Green Version]
  119. Tahir, M.J.; Haapala, J.L.; Foster, L.P.; Duncan, K.M.; Teague, A.M.; Kharbanda, E.O.; McGovern, P.M.; Whitaker, K.M.; Rasmussen, K.M.; Fields, D.A.; et al. Higher Maternal Diet Quality during Pregnancy and Lactation Is Associated with Lower Infant Weight-For-Length, Body Fat Percent, and Fat Mass in Early Postnatal Life. Nutrients 2019, 11, 632. [Google Scholar] [CrossRef] [Green Version]
  120. Chatzi, L.; Rifas-Shiman, S.L.; Georgiou, V.; Joung, K.E.; Koinaki, S.; Chalkiadaki, G.; Margioris, A.; Sarri, K.; Vassilaki, M.; Vafeiadi, M.; et al. Adherence to the Mediterranean diet during pregnancy and offspring adiposity and cardiometabolic traits in childhood. Pediatric Obes. 2017, 12, 47–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  121. Fernández-Barrés, S.; Romaguera, D.; Valvi, D.; Martínez, D.; Vioque, J.; Navarrete-Muñoz, E.M.; Amiano, P.; Gonzalez-Palacios, S.; Guxens, M.; Pereda, E.; et al. Mediterranean dietary pattern in pregnant women and offspring risk of overweight and abdominal obesity in early childhood: The INMA birth cohort study. Pediatric Obes. 2016, 11, 491–499. [Google Scholar] [CrossRef] [PubMed]
  122. Okubo, H.; Crozier, S.R.; Harvey, N.C.; Godfrey, K.M.; Inskip, H.M.; Cooper, C.; Robinson, S.M. Maternal dietary glycemic index and glycemic load in early pregnancy are associated with offspring adiposity in childhood: The Southampton Women’s Survey. Am. J. Clin. Nutr. 2014, 100, 676–683. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  123. Chen, L.-W.; Aubert, A.M.; Shivappa, N.; Bernard, J.Y.; Mensink-Bout, S.M.; Geraghty, A.A.; Mehegan, J.; Suderman, M.; Polanska, K.; Hanke, W.; et al. Maternal dietary quality, inflammatory potential and childhood adiposity: An individual participant data pooled analysis of seven European cohorts in the ALPHABET consortium. BMC Med. 2021, 19, 33. [Google Scholar] [CrossRef]
  124. Forkert, E.C.O.; Rendo-Urteaga, T.; Nascimento-Ferreira, M.V.; de Moraes, A.C.F.; Moreno, L.A.; de Carvalho, H.B. Abdominal obesity and cardiometabolic risk in children and adolescents, are we aware of their relevance? Nutrire 2016, 41, 15. [Google Scholar] [CrossRef] [Green Version]
  125. Lee, H.; Lee, I.S.; Choue, R. Obesity, inflammation and diet. Pediatr. Gastroenterol. Hepatol. Nutr. 2013, 16, 143–152. [Google Scholar] [CrossRef] [Green Version]
  126. Donahue, S.M.; Rifas-Shiman, S.L.; Gold, D.R.; Jouni, Z.E.; Gillman, M.W.; Oken, E. Prenatal fatty acid status and child adiposity at age 3 y: Results from a US pregnancy cohort. Am. J. Clin. Nutr. 2011, 93, 780–788. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  127. Burton, G.J.; Fowden, A.L.; Thornburg, K.L. Placental Origins of Chronic Disease. Physiol. Rev. 2016, 96, 1509–1565. [Google Scholar] [CrossRef] [PubMed]
  128. Desoye, G.; Cervar-Zivkovic, M. Diabetes Mellitus, Obesity, and the Placenta. Obs. Gynecol. Clin. N. Am. 2020, 47, 65–79. [Google Scholar] [CrossRef]
  129. Ten-Teachers. Obstetrics, 20th ed.; CRC Press Taylor & Francis Group: Boca Raton, FL, USA, 2017; pp. 86–92. [Google Scholar]
  130. Brett, K.E.; Ferraro, Z.M.; Yockell-Lelievre, J.; Gruslin, A.; Adamo, K.B. Maternal-fetal nutrient transport in pregnancy pathologies: The role of the placenta. Int. J. Mol. Sci. 2014, 15, 16153–16185. [Google Scholar] [CrossRef] [Green Version]
  131. Larsen, S.; Bjelland, E.K.; Haavaldsen, C.; Eskild, A. Placental weight in pregnancies with high or low hemoglobin concentrations. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016, 206, 48–52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Eriksson, J.G.; Gelow, J.; Thornburg, K.L.; Osmond, C.; Laakso, M.; Uusitupa, M.; Lindi, V.; Kajantie, E.; Barker, D.J.P. Long-Term Effects of Placental Growth on Overweight and Body Composition. Int. J. Pediatrics 2012, 2012, 324185. [Google Scholar] [CrossRef] [PubMed]
  133. Cetin, I.; Berti, C.; Calabrese, S. Role of micronutrients in the periconceptional period. Hum. Reprod. Update 2010, 16, 80–95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  134. Desoye, G. The Human Placenta in Diabetes and Obesity: Friend or Foe? The 2017 Norbert Freinkel Award Lecture. Diabetes Care 2018, 41, 1362–1369. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  135. Meakin, A.S.; Cuffe, J.S.M.; Darby, J.R.T.; Morrison, J.L.; Clifton, V.L. Let’s Talk about Placental Sex, Baby: Understanding Mechanisms That Drive Female- and Male-Specific Fetal Growth and Developmental Outcomes. Int. J. Mol. Sci. 2021, 22, 6386. [Google Scholar] [CrossRef] [PubMed]
  136. Donnelly, J.M.T.; Horan, M.; Segurado, R.; Mooney, E.E.; French, S.; Molloy, E.J.; McAuliffe, F.M. Sexual dimorphism and the placenta-results from the ROLO kids study. J. Matern. Fetal Neonatal. Med. 2020, 1–7. [Google Scholar] [CrossRef] [PubMed]
  137. Bernadette, C.B.; Dexter, J.L.H.; Rebecca, L.J. Effects of micronutrients on placental function: Evidence from clinical studies to animal models. Reproduction 2018, 156, R69–R82. [Google Scholar] [CrossRef] [Green Version]
  138. Bayol, S.A.; Farrington, S.J.; Stickland, N.C. A maternal ‘junk food’ diet in pregnancy and lactation promotes an exacerbated taste for ‘junk food’ and a greater propensity for obesity in rat offspring. Br. J. Nutr. 2007, 98, 843–851. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  139. Dekker Nitert, M.; Vaswani, K.; Hum, M.; Chan, H.-W.; Wood-Bradley, R.; Henry, S.; Armitage, J.A.; Mitchell, M.D.; Rice, G.E. Maternal high-fat diet alters expression of pathways of growth, blood supply and arachidonic acid in rat placenta. J. Nutr. Sci. 2014, 2, e41. [Google Scholar] [CrossRef] [Green Version]
  140. Wentzel, P.; Eriksson, U.J.; Herrera, E. High-fat diet in pregnant rats and adverse fetal outcome. Upsala J. Med. Sci. 2019, 124, 125–134. [Google Scholar] [CrossRef] [Green Version]
  141. Tellechea, M.L.; Mensegue, M.F.; Pirola, C.J. The Association between High Fat Diet around Gestation and Metabolic Syndrome-related Phenotypes in Rats: A Systematic Review and Meta-Analysis. Sci. Rep. 2017, 7, 5086. [Google Scholar] [CrossRef] [PubMed]
  142. Kereliuk, S.M.; Brawerman, G.M.; Dolinsky, V.W. Maternal Macronutrient Consumption and the Developmental Origins of Metabolic Disease in the Offspring. Int. J. Mol. Sci 2017, 18, 1451. [Google Scholar] [CrossRef] [PubMed]
  143. Toblli, J.E.; Cao, G.; Oliveri, L.; Angerosa, M. Effects of iron deficiency anemia and its treatment with iron polymaltose complex in pregnant rats, their fetuses and placentas: Oxidative stress markers and pregnancy outcome. Placenta 2012, 33, 81–87. [Google Scholar] [CrossRef]
  144. Rosario, F.J.; Nathanielsz, P.W.; Powell, T.L.; Jansson, T. Maternal folate deficiency causes inhibition of mTOR signaling, down-regulation of placental amino acid transporters and fetal growth restriction in mice. Sci. Rep. 2017, 7, 3982. [Google Scholar] [CrossRef]
  145. Parisi, F.; Savasi, V.M.; di Bartolo, I.; Mandia, L.; Cetin, I. Associations between First Trimester Maternal Nutritional Score, Early Markers of Placental Function, and Pregnancy Outcome. Nutrients 2020, 12, 1799. [Google Scholar] [CrossRef]
  146. Sharma, S.S.; Greenwood, D.C.; Simpson, N.A.B.; Cade, J.E. Is dietary macronutrient composition during pregnancy associated with offspring birth weight? An observational study. Br. J. Nutr. 2018, 119, 330–339. [Google Scholar] [CrossRef] [Green Version]
  147. Schwingshackl, L.; Zähringer, J.; Beyerbach, J.; Werner, S.W.; Heseker, H.; Koletzko, B.; Meerpohl, J.J. Total Dietary Fat Intake, Fat Quality, and Health Outcomes: A Scoping Review of Systematic Reviews of Prospective Studies. Ann. Nutr. Metab. 2021, 77, 4–15. [Google Scholar] [CrossRef]
  148. Kabaran, S.; Besler, H.T. Do fatty acids affect fetal programming? J. Health Popul. Nutr. 2015, 33, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  149. Herring, C.M.; Bazer, F.W.; Johnson, G.A.; Wu, G. Impacts of maternal dietary protein intake on fetal survival, growth, and development. Exp. Biol. Med. 2018, 243, 525–533. [Google Scholar] [CrossRef] [PubMed]
  150. Hindmarsh, P.C.; Geary, M.P.; Rodeck, C.H.; Jackson, M.R.; Kingdom, J.C. Effect of early maternal iron stoRes. on placental weight and structure. Lancet 2000, 356, 719–723. [Google Scholar] [CrossRef]
  151. Wiertsema Clarissa, J.; Mensink-Bout Sara, M.; Duijts, L.; Mulders Annemarie, G.M.G.J.; Jaddoe Vincent, W.V.; Gaillard, R. Associations of DASH Diet in Pregnancy With Blood Pressure Patterns, Placental Hemodynamics, and Gestational Hypertensive Disorders. J. Am. Heart Assoc. 2021, 10, e017503. [Google Scholar] [CrossRef]
  152. Deans, C.; Maggert, K.A. What do you mean, “epigenetic”? Genetics 2015, 199, 887–896. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  153. Aguilera, O.; Fernández, A.F.; Muñoz, A.; Fraga, M.F. Epigenetics and environment: A complex relationship. J. Appl. Physiol. 2010, 109, 243–251. [Google Scholar] [CrossRef] [Green Version]
  154. Weinhold, B. Epigenetics: The Science of Change. Environ. Health Perspect. 2006, 114, A160–A167. [Google Scholar] [CrossRef] [Green Version]
  155. Gibney, E.R.; Nolan, C.M. Epigenetics and gene expression. Heredity 2010, 105, 4–13. [Google Scholar] [CrossRef] [Green Version]
  156. Heijmans, B.T.; Tobi, E.W.; Lumey, L.H.; Slagboom, P.E. The epigenome: Archive of the prenatal environment. Epigenetics 2009, 4, 526–531. [Google Scholar] [CrossRef] [Green Version]
  157. Waterland, R.A.; Michels, K.B. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 2007, 27, 363–388. [Google Scholar] [CrossRef] [PubMed]
  158. Słupecka-Ziemilska, M.; Wychowański, P.; Puzianowska-Kuznicka, M. Gestational Diabetes Mellitus Affects Offspring’s Epigenome. Is There a Way to Reduce the Negative Consequences? Nutrients 2020, 12, 2792. [Google Scholar] [CrossRef]
  159. Wajed, S.A.; Laird, P.W.; DeMeester, T.R. DNA methylation: An alternative pathway to cancer. Ann. Surg. 2001, 234, 10–20. [Google Scholar] [CrossRef]
  160. Waterland, R.A.; Jirtle, R.L. Transposable Elements: Targets for Early Nutritional Effects on Epigenetic Gene Regulation. Mol. Cell. Biol. 2003, 23, 5293–5300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  161. Steegers-Theunissen, R.P.; Twigt, J.; Pestinger, V.; Sinclair, K.D. The periconceptional period, reproduction and long-term health of offspring: The importance of one-carbon metabolism. Hum. Reprod. Update 2013, 19, 640–655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  162. Pauwels, S.; Ghosh, M.; Duca, R.C.; Bekaert, B.; Freson, K.; Huybrechts, I.; Langie, S.A.S.; Koppen, G.; Devlieger, R.; Godderis, L. Maternal intake of methyl-group donors affects DNA methylation of metabolic genes in infants. Clin. Epigenetics 2017, 9, 16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  163. Dominguez-Salas, P.; Moore, S.E.; Baker, M.S.; Bergen, A.W.; Cox, S.E.; Dyer, R.A.; Fulford, A.J.; Guan, Y.; Laritsky, E.; Silver, M.J.; et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat. Commun. 2014, 5, 3746. [Google Scholar] [CrossRef]
  164. Waterland, R.A.; Kellermayer, R.; Laritsky, E.; Rayco-Solon, P.; Harris, R.A.; Travisano, M.; Zhang, W.; Torskaya, M.S.; Zhang, J.; Shen, L.; et al. Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet. 2010, 6, e1001252. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  165. Rakyan, V.K.; Blewitt, M.E.; Druker, R.; Preis, J.I.; Whitelaw, E. Metastable epialleles in mammals. Trends Genet 2002, 18, 348–351. [Google Scholar] [CrossRef]
  166. Ba, Y.; Yu, H.; Liu, F.; Geng, X.; Zhu, C.; Zhu, Q.; Zheng, T.; Ma, S.; Wang, G.; Li, Z.; et al. Relationship of folate, vitamin B12 and methylation of insulin-like growth factor-II in maternal and cord blood. Eur. J. Clin. Nutr. 2011, 65, 480–485. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  167. Haggarty, P.; Hoad, G.; Campbell, D.M.; Horgan, G.W.; Piyathilake, C.; McNeill, G. Folate in pregnancy and imprinted gene and repeat element methylation in the offspring. Am. J. Clin. Nutr. 2013, 97, 94–99. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  168. Caffrey, A.; Irwin, R.E.; McNulty, H.; Strain, J.J.; Lees-Murdock, D.J.; McNulty, B.A.; Ward, M.; Walsh, C.P.; Pentieva, K. Gene-specific DNA methylation in newborns in response to folic acid supplementation during the second and third trimesters of pregnancy: Epigenetic analysis from a randomized controlled trial. Am. J. Clin. Nutr. 2018, 107, 566–575. [Google Scholar] [CrossRef] [PubMed]
  169. Franzago, M.; Fraticelli, F.; Stuppia, L.; Vitacolonna, E. Nutrigenetics, epigenetics and gestational diabetes: Consequences in mother and child. Epigenetics 2019, 14, 215–235. [Google Scholar] [CrossRef] [Green Version]
  170. Geraghty, A.A.; Sexton-Oates, A.; O’Brien, E.C.; Alberdi, G.; Fransquet, P.; Saffery, R.; McAuliffe, F.M. A Low Glycaemic Index Diet in Pregnancy Induces DNA Methylation Variation in Blood of Newborns: Results from the ROLO Randomised Controlled Trial. Nutrients 2018, 10, 455. [Google Scholar] [CrossRef] [Green Version]
  171. Geraghty, A.A.; Sexton-Oates, A.; O’Brien, E.C.; Saffery, R.; McAuliffe, F.M. Epigenetic Patterns in Five-Year-Old Children Exposed to a Low Glycemic Index Dietary Intervention during Pregnancy: Results from the ROLO Kids Study. Nutrients 2020, 12, 3602. [Google Scholar] [CrossRef] [PubMed]
  172. Yan, W.; Zhang, Y.; Wang, L.; Yang, W.; Li, C.; Wang, L.; Gu, P.; Xia, Y.; Yan, J.; Shen, Y.; et al. Maternal dietary glycaemic change during gestation influences insulin-related gene methylation in the placental tissue: A genome-wide methylation analysis. Genes Nutr. 2019, 14, 17. [Google Scholar] [CrossRef]
  173. Antoun, E.; Kitaba, N.T.; Titcombe, P.; Dalrymple, K.V.; Garratt, E.S.; Barton, S.J.; Murray, R.; Seed, P.T.; Holbrook, J.D.; Kobor, M.S.; et al. Maternal dysglycaemia, changes in the infant’s epigenome modified with a diet and physical activity intervention in pregnancy: Secondary analysis of a randomised control trial. PLoS Med. 2020, 17, e1003229. [Google Scholar] [CrossRef]
  174. Zhang, Q.; Xiao, X.; Zheng, J.; Li, M.; Yu, M.; Ping, F.; Wang, T.; Wang, X. A Maternal High-Fat Diet Induces DNA Methylation Changes That Contribute to Glucose Intolerance in Offspring. Front. Endocrinol. 2019, 10, 871. [Google Scholar] [CrossRef] [Green Version]
  175. Gali Ramamoorthy, T.; Allen, T.J.; Davies, A.; Harno, E.; Sefton, C.; Murgatroyd, C.; White, A. Maternal overnutrition programs epigenetic changes in the regulatory regions of hypothalamic Pomc in the offspring of rats. Int. J. Obes. 2018, 42, 1431–1444. [Google Scholar] [CrossRef] [Green Version]
  176. Dudley, K.J.; Sloboda, D.M.; Connor, K.L.; Beltrand, J.; Vickers, M.H. Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. PLoS ONE 2011, 6, e21662. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  177. Hanson, M.; Godfrey, K.M.; Lillycrop, K.A.; Burdge, G.C.; Gluckman, P.D. Developmental plasticity and developmental origins of non-communicable disease: Theoretical considerations and epigenetic mechanisms. Prog. Biophys. Mol. Biol. 2011, 106, 272–280. [Google Scholar] [CrossRef]
  178. Lee, H.S. Impact of Maternal Diet on the Epigenome during In Utero Life and the Developmental Programming of Diseases in Childhood and Adulthood. Nutrients 2015, 7, 9492–9507. [Google Scholar] [CrossRef] [Green Version]
  179. Heijmans, B.T.; Tobi, E.W.; Stein, A.D.; Putter, H.; Blauw, G.J.; Susser, E.S.; Slagboom, P.E.; Lumey, L.H. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. USA 2008, 105, 17046–17049. [Google Scholar] [CrossRef] [Green Version]
  180. Martin, C.L.; Jima, D.; Sharp, G.C.; McCullough, L.E.; Park, S.S.; Gowdy, K.M.; Skaar, D.; Cowley, M.; Maguire, R.L.; Fuemmeler, B.; et al. Maternal pre-pregnancy obesity, offspring cord blood DNA methylation, and offspring cardiometabolic health in early childhood: An epigenome-wide association study. Epigenetics 2019, 14, 325–340. [Google Scholar] [CrossRef] [Green Version]
  181. Sharp, G.C.; Lawlor, D.A.; Richmond, R.C.; Fraser, A.; Simpkin, A.; Suderman, M.; Shihab, H.A.; Lyttleton, O.; McArdle, W.; Ring, S.M.; et al. Maternal pre-pregnancy BMI and gestational weight gain, offspring DNA methylation and later offspring adiposity: Findings from the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 2015, 44, 1288–1304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  182. Sharp, G.C.; Salas, L.A.; Monnereau, C.; Allard, C.; Yousefi, P.; Everson, T.M.; Bohlin, J.; Xu, Z.; Huang, R.C.; Reese, S.E.; et al. Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: Findings from the pregnancy and childhood epigenetics (PACE) consortium. Hum. Mol. Genet. 2017, 26, 4067–4085. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  183. Gonzalez-Nahm, S.; Mendez, M.; Robinson, W.; Murphy, S.K.; Hoyo, C.; Hogan, V.; Rowley, D. Low maternal adherence to a Mediterranean diet is associated with increase in methylation at the MEG3-IG differentially methylated region in female infants. Environ. Epigenet. 2017, 3, dvx007. [Google Scholar] [CrossRef] [PubMed]
  184. House, J.S.; Mendez, M.; Maguire, R.L.; Gonzalez-Nahm, S.; Huang, Z.; Daniels, J.; Murphy, S.K.; Fuemmeler, B.F.; Wright, F.A.; Hoyo, C. Periconceptional Maternal Mediterranean Diet Is Associated With Favorable Offspring Behaviors and Altered CpG Methylation of Imprinted Genes. Front. Cell Dev. Biol. 2018, 6, 107. [Google Scholar] [CrossRef] [PubMed]
  185. Hoyo, C.; Murphy, S.K.; Jirtle, R.L. ImprInt. regulatory elements as epigenetic biosensors of exposure in epidemiological studies. J. Epidemiol. Community Health 2009, 63, 683–684. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  186. Robinson, D.P.; Klein, S.L. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm. Behav. 2012, 62, 263–271. [Google Scholar] [CrossRef] [Green Version]
  187. Campbell, J.M.; McPherson, N.O. Influence of increased paternal BMI on pregnancy and child health outcomes independent of maternal effects: A systematic review and meta-analysis. Obes. Res. Clin. Pract. 2019, 13, 511–521. [Google Scholar] [CrossRef]
  188. Noor, N.; Cardenas, A.; Rifas-Shiman, S.L.; Pan, H.; Dreyfuss, J.M.; Oken, E.; Hivert, M.F.; James-Todd, T.; Patti, M.E.; Isganaitis, E. Association of Periconception Paternal Body Mass Index With Persistent Changes in DNA Methylation of Offspring in Childhood. JAMA Netw. Open 2019, 2, e1916777. [Google Scholar] [CrossRef] [PubMed]
  189. Fielding-Singh, P. Dining with dad: Fathers’ influences on family food practices. Appetite 2017, 117, 98–108. [Google Scholar] [CrossRef] [PubMed]
  190. Broere-Brown, Z.A.; Baan, E.; Schalekamp-Timmermans, S.; Verburg, B.O.; Jaddoe, V.W.; Steegers, E.A. Sex-specific differences in fetal and infant growth patterns: A prospective population-based cohort study. Biol. Sex Differ. 2016, 7, 65. [Google Scholar] [CrossRef] [Green Version]
  191. Phang, M.; Ross, J.; Raythatha, J.H.; Dissanayake, H.U.; McMullan, R.L.; Kong, Y.; Hyett, J.; Gordon, A.; Molloy, P.; Skilton, M.R. Epigenetic aging in newborns: Role of maternal diet. Am. J. Clin. Nutr. 2020, 111, 555–561. [Google Scholar] [CrossRef]
  192. Lazarides, C.; Epel, E.S.; Lin, J.; Blackburn, E.H.; Voelkle, M.C.; Buss, C.; Simhan, H.N.; Wadhwa, P.D.; Entringer, S. Maternal pro-inflammatory state during pregnancy and newborn leukocyte telomere length: A prospective investigation. Brain Behav. Immun. 2019, 80, 419–426. [Google Scholar] [CrossRef]
  193. Lee, Y.; Sun, D.; Ori, A.P.S.; Lu, A.T.; Seeboth, A.; Harris, S.E.; Deary, I.J.; Marioni, R.E.; Soerensen, M.; Mengel-From, J.; et al. Epigenome-wide association study of leukocyte telomere length. Aging 2019, 11, 5876–5894. [Google Scholar] [CrossRef]
Table 1. Summary of Dietary Metric Components.
Table 1. Summary of Dietary Metric Components.
Dietary ScoreFood Components and CalculationInterpretationDietary Assessment Method
Dietary Inflammatory Index (DII)
[30]
Literature-based index measuring the effect of 45 food parameters (a mix of macro- and micro-nutrient food components such as alcohol; vitamin B12; β-carotene; caffeine; carbohydrate; cholesterol; fibre; folic acid; garlic; ginger; iron; monounsaturated fat) on six inflammatory biomarkers (IL-1β, IL-4, IL-6, IL-10, TNF-α and C-reactive protein).Higher values of the DII indicate a pro-inflammatory (i.e., less healthy) dietary profile, whereas lower values indicate an anti-inflammatory (i.e., more healthy) dietary profile. Using the energy-adjusted DII (E-DII) score is often more reliable as it is associated with improved prediction in comparison to unadjusted DII scores.Food Frequency Questionnaire or 24-h recall
Mediterranean Diet (MD)
[54,55]
Varying food components across different indices. Most useful indices base calculation of 9 components:
- High intake of the non-Mediterranean foods: dairy and meat were scored negative as (0)
- High intake of Mediterranean foods: cereals, legumes, fruit, vegetables, fish, Monounsaturated fatty acids to Saturated fatty acids (MUFA-SFA) ratio, and wine which were scored positive as (1)
A metric indicating compliance to the Mediterranean diet pattern in adults.
Across the different MD indices, ranges calculated that generate higher values indicate greater MD adherence.
A score of 0–3 represents low adherence, a score of 4–6 represents moderate adherence and a score of 7–9 represents high adherence to the Mediterranean diet
Food Frequency Questionnaire
Healthy Eating Index 2010
(HEI-2010)
[56]
12 components in total 9 adequacy components: Total Fruit, Whole Fruit (forms other than juice), Total Vegetables, Greens and Beans (dark-green vegetables and beans and peas), Whole Grains, Dairy (all milk products and soy beverages), Total Protein Foods, Seafood and Plant Proteins, and Fatty Acids (ratio of polyunsaturated fatty acids [PUFA] and MUFA to SFA). Scored 10 in the highest consumption and 0 in the lowest.
3 moderation components are: Refined Grains, Sodium, and Empty Calories (all calories from solid fats & added sugars plus calories from alcohol beyond a moderate level) scored 10 in the lowest consumption
Measure of overall diet quality that measures alignment with the 2010 Dietary Guidelines for Americans
Scored on a density basis out of 1000 calories
An HEI score between 51 and 80 is considered as “needing dietary improvement”
Food Frequency Questionnaire
HEI-2015
[57]
13 components in total
The HEI-2015 components are the same as in the HEI-2010, except Saturated Fat and Added Sugars replace Empty Calories. Previous versions of the HEI accounted for legumes in either the two vegetable or the two protein foods components, whereas HEI-2015 counts legumes toward all four components.
Measure of overall diet quality that measures alignment with the updated 2015–2020 Dietary Guidelines for Americans that are scored on a density basis out of 1000 calories.
A HEI score between 51 and 80 is considered as “needing dietary improvement”
Food Frequency Questionnaire
AHEI-2010
[58,59]
11 components in total:
Vegetables; fruit; whole grains; sugar-sweetened beverages; nuts and legumes; red and processed meat; trans fats; long-chain (n-3) fatty acids (eicosapentaenoic acid and docosahexaenoic acid); polyunsaturated fatty acid; sodium; alcohol
An alternative version of the HEI that focuses on adherence to a dietary pattern associated with chronic disease risk and pays more attention to fat quality (i.e., intakes of omega-3 fats and polyunsaturated fats)
Assess diet adequacy and moderation
Food Frequency Questionnaire
Dietary Approaches to Stop Hypertension
(DASH)
[60,61]
8 components: Fruit, vegetables, nuts and legumes, whole grains, low-fat dairy products, sodium, red and processed meats, and sweetened beverages
The lowest intake of healthy components (fruits, vegetables, nuts and legumes, low-fat dairy products, and whole grains) receive one point and the top quintile receives 5 points.
The scoring for the remaining unhealthy components is reversely coded so that quintile 1 receives 5 points and quintile 5 receives one point
Sex-specific intake quintiles are generated for each of the 8 components.
The overall score ranges from 8 (the lowest adherence) to 40 (the highest adherence)
Food Frequency Questionnaire
Glycaemic index and load
(GI and GL)
[62]
GI is a way of ranking carbohydrate foods based on the rate at which they raise blood glucose levels.
GL estimates the impact of carbohydrate intake using the GI while accounting for serving size.
GL = GI × carbohydrate in a serving/100
Foods that are digested quickly (e.g., refined, starchy grains and fruit juices) will raise blood glucose levels quickly and therefore are given higher GI/GL values
A GL classification system is used in which foods are categorized as having low (≤10), medium (>10–<20) or high GL (≥20).
Food Frequency Questionnaire
Table 2. Individual studies on the associations between maternal dietary inflammation determined by the DII and E-DII and birth outcomes.
Table 2. Individual studies on the associations between maternal dietary inflammation determined by the DII and E-DII and birth outcomes.
First Author, YearCountry or SettingStudy DesignPopulationDietary Assessment Method and PeriodAssessment of Adherence to the DietBirth OutcomesKey Findings
Navarro et al., 2019 [24]Ireland, 2001–2003Lifeways Cross-Generation Cohort Study: A prospective family study1082 mother-child pairsSemi-quantitative Food frequency questionnaires (FFQ), consumption during the first
12–16 weeks of pregnancy
Calculation of E-DII score based on 28 food parameters: carbohydrate, protein, fat, alcohol, fibre, cholesterol, saturated fat,
mono-unsaturated fat, poly-unsaturated fat, niacin, thiamin, riboflavin, vitamin B12, vitamin B6, iron, magnesium, zinc, selenium, beta-caro-
tene, vitamin A, vitamin C, vitamin D, vitamin E, folic acid, onion, garlic, tea and caffeine.
Low birthweight, macrosomia, per-term and post-term birthHigher maternal E-DII scores were associated with increased risk of low birthweight
Higher maternal grandmothers E-DII scores were associated with increased risk of macrosomia
Moore et al., 2018 [86]USA, 2009–2014Healthy Start study: A prospective pre-birth cohort.1078 mother-child-pairs with neonates born ≥32 weeks of gestation, and mothers with pre-pregnancy BMI ≥18.5 kg/m2Repeated 24-h dietary recalls completed each month during pregnancyDII scores based on 28 components: energy, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, omega-3 polyunsaturated fatty acids, omega-6 fatty acids, trans-fat, carbohydrates, fiber, protein, cholesterol, iron, Vitamin A, Vitamin C, Vitamin D, Vitamin E, niacin, thiamin, riboflavin, Vitamin B6, Vitamin B12, folic acid, magnesium, zinc, selenium, alcohol and caffeineBirth weight, fat mass, fat-free mass and percent fat mass, small and large for gestational age (LGA)Among neonates born to obese women, each one-unit increase in DII was associated with increased birth weight, fat mass and percent fat mass
One-unit increase in DII score was associated with a tendency of increased risk of having a LGA infant
McCullough et al., 2017
[14]
USA, 2009–2011NEST study: A prospective cohort study of pregnant women1057 mother–child pairs with singleton deliveriesFFQs were administered at different time points: (1) at enrolment with a description of the diet during the periconceptional period; (2) during the second trimester to estimate usual diet in the first trimester; (3) between 36- week gestation and delivery date to estimate diet in the last 2 trimesters of pregnancy; and (4) at deliveryCalculation of E-DII score based on 27 food parameters: Carbohydrates, proteins, fats, alcohol, fibres, cholesterol, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, omega 3, omega 6, niacin, thiamin, riboflavin, vitamin B6, vitamin B12, iron, magnesium, zinc, selenium, vitamin A, vitamin C, vitamin D, vitamin E, folic acid, β carotene and caffeineSex-specific percentiles of birthweight for gestational age, small and large for gestational age, gestational age, mode of deliveryWomen with pro-inflammatory diets had elevated rates of preterm birth among female offspring No association between infant birthweight and maternal E-DII score was observed
Sen et al., 2016
[15]
USA, 1999–2002Project Viva, a pre–birth cohort study1808 mother–child pairs with a pre-pregnancy BMI (in kg/m2) ≥18.5 without pre-existing type 1 or 2 diabetes mellitusFFQ administered at the first and second trimesterDII based on 28 components:
energy, carbohydrate, protein, fat, alcohol, fibre, cholesterol, SFAs, MUFAs, PUFAs, n–3 and n–6 FAs, trans-fat, niacin, thiamin, riboflavin, vitamin B-12, vitamin B-6, iron, magnesium, zinc, selenium, vitamin A, vitamin C, vitamin D, vitamin E, folic acid and β-carotene.
Birth weight for gestational age, premature birthHigher DII scores were associated with lower birth weight for gestational age z score in infants born to obese mothers
Table 3. Individual studies on the associations between maternal dietary quality determined by the Mediterranean diet score and birth outcomes.
Table 3. Individual studies on the associations between maternal dietary quality determined by the Mediterranean diet score and birth outcomes.
First Author, YearCountry or
Setting
Study DesignPopulationDietary Assessment Method and PeriodAssessment of
Adherence to the Diet
Birth OutcomesKey Findings
Yisahak et al., 2021 [92]USA,
2009–2013
Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singletons: Prospective cohort2802 pregnant womenFFQ in first trimesterTrichopoulou’s score [71]Birthweight, length, upper arm length, head circumference, abdominal circumference, sum of skinfold thick-ness, prematurity, SGA, LGA, low birth weight (LBW), macrosomiaGreater MD is associated with higher birthweight, reduced odds of LBW, increased birth length, upper arm length, significant p-trend for sum of skinfolds
Peraita-Costa et al., 2020
[93]
Spain, 2018–2019Two-phase retrospective population-based study1118 mother–child pairs admitted after deliverySemi-quantitative FFQ (16 items), self-administered after deliveryKidmex scores [72]SGA and preterm birthMedium adherence to MD was associated with a higher risk of giving birth to a preterm newborn.
No association was found between MD adherence and SGA
Martinez-Galiano et al., 2018 [94]Spain, 2012–2015Prospective multicentre matched case-control study (The matching criterion was the maternal age at delivery)518 mothers of singleton SGA infants, 518 mothers of singleton infants with normal weight for gestational ageSemi-quantitative FFQ, administered 2 days after deliveryPREDIMED score [95],
Trichopoulou’s score [71],
Panagiotakos’ score [96]
Small for gestational-age (SGA) riskMD adherence was associated to a reduced risk of SGA in newborns
Gomez-Roig et al., 2017 [97]Spain, over 14 monthsCross-sectional study46 mothers with SGA foetuses, 81 mothers with appropriate for gestational age (AGA) foetusesSemi-quantitative FFQ, administered during the third trimesterTrichopoulou’s score [71]SGA riskMothers maintaining a Mediterranean-type diet were more likely to have an AGA foetus
Saunders et al., 2014 [90]French Caribbean Island (Guadeloupe), 2004–2007TIMOUN Study: Prospective mother–child cohort study728 pregnant women with a live-born singleton pregnancy without major congenital malformationsSemi-quantitative FFQ, diet during pregnancyTrichopoulou’s score [71]Preterm delivery and risk of foetal growth restriction (FGR)No association between MD adherence during pregnancy and the risk of prematurity or FGR
MD adherence was associated with a decreased risk of prematurity specifically in overweight and obese women
Timmermans et al., 2012
[88]
Netherlands, 2001–2006Generation R study, prospective population-based cohort study3207 mothers with a
spontaneously conceived live-born singleton pregnancy
Semi quantitative FFQ, Early pregnancy < 18 weeksDietary pattern identified and labelled MD as it was characterized by higher intakes of pasta, rice, vegetable oils, fish, vegetables and alcohol, and lower intakes of meat, potatoes and fatty saucesFoetal growth, placenta developmentLow MD adherence resulted associated with lower birth weight and placental weight
Chatzi et al., 2011
[89]
Spain 2004-2007, Greece 2007–2008INMA (Spain) and RHEA (Crete) cohorts: Prospective population-based cohort studySpain: 2461 mother–newborn pairs. Greece: 889 mother–newborn pairsSemi-quantitative FFQ, administered during first (IMNA cohort) or mid trimester (RHEA cohort) of pregnancyTrichopoulou’s score modified for pregnancy [71]Foetal growthINMA-Mediterranean cohort: high MD adherence was associated with higher BW and reduced risk of foetal growth restriction
In all cohorts, high MD increased birth weight in smoking mothers
Mikkelsen et al., 2010 [91]Denmark, 1996–2002Danish National Birth Cohort: prospective cohort study35657 pregnant women with a live-born singleton pregnancySemi-quantitative FFQ, self-administered at mid pregnancyKhoury’s score [74]Preterm deliveryReduced risk of early preterm delivery in MD women
Haugen et al., 2008 [73]Norway, 2002–2005Norwegian Mother and Child Cohort Study (MoBa): prospective cohort study26563 pregnant women with a live-born singleton pregnancySemi quantitative FFQ, administered at mid pregnancyKhoury’s score [74]Preterm deliveryNo association with reduced risk of preterm birth
Trichopoulou’s score: Nine components including beneficial components (vegetables, legumes, fruits and nuts, cereal and fish), detrimental components (meat, dairy products, alcohol consumption) and fat intake. In pregnancy, dairy products are not considered detrimental and alcohol consumption is not included. Mediterranean-diet score ranged from 0 to 9. Khoury’ score: 5 MD criteria in the current study were defined by the intake of ≥5 vegetables and fruit/d, ≥2 servings of fish/wk, the use of olive or canola oil for cooking and salad dressings, ≤2 servings of red meat/wk, and ≤2 cups of coffee/d. PREDIMED score: development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Vegetables, legumes, fruit, fish, red and processed meat, chicken or poultry, olive oil for cooking, consumption of olive oil, butter-margarine, carbonated and/or sweetened beverages, commercial pastries, nuts and meals with sofrito (traditional sauce of tomatoes, garlic, onion or pepper in olive oil). The total score ranged from 0 (minimum adherence) to 14 (maximum adherence). Kidmex score: Based on the principles sustaining MD patterns as well as those that undermine it. Foods positively associated with the MD pattern, such as vegetables, legumes, fruits, nuts, cereal, fish, dairy products and olive oil, were assigned a value of +1, whereas foods with a negative association such as sweets and fast foods were assigned a value of –1. The score ranged from 0 to 12.
Table 4. Individual studies on the associations between maternal dietary quality determined by the Healthy Eating Index and birth outcomes.
Table 4. Individual studies on the associations between maternal dietary quality determined by the Healthy Eating Index and birth outcomes.
First Author, YearCountry or SettingStudy DesignPopulationDietary Assessment Method and PeriodAssessment of Adherence to the DietBirth OutcomesKey Findings
Zhu et al., 2019 [103]United States, 2014–2017Pregnancy Environment and Lifestyle Study: A prospective cohort2269 multi-racial/ethnic womenFFQ during early pregnancy (10–13 weeks) that collected information on habitual dietary intake during the previous 3 months.HEI-2010 [64]
Exclusion of alcohol consumption
Birthweight z-score, large- and small-for-gestational age79% of pregnant women did not adhere to the Dietary Guidelines for Americans.
Poor diet quality in pregnancy was associated with higher birthweight and increased risk of LGA independent of maternal obesity and other covariates
Navarro et al., 2019
[104]
Ireland, 2001–2003Lifeways cross generation cohort study: prospective family study1082 families at birthSemi quantitative FFQ during the first trimester of pregnancyThe HEI-2015 [57]Birth weight, macrosomia, premature birthHigher scores on the maternal HEI were associated with lower risk of low birth weight. Similar associations were found for maternal grandmothers with higher HEI scores, but a slightly risk of macrosomia was observed
Chia et al., 2018 [105]Singapore, 2009–2010The GUSTO Study, a prospective mother-offspring cohort1051 pregnant women24-h recalls at 26–28 weeks of gestationThey used the HEI-SGP (11 components with a maximum possible raw score of 90) *Preterm birth, offspring birth size, and adiposityHigher maternal diet quality during pregnancy was associated with longer birth length and lower neonatal adiposity
No associations with birth weight or preterm birth
Badon et al., 2017 [100]United States, 1996–2008Omega study, a prospective pregnancy cohort2924 women with singleton live birthsSelf-administered semi-quantitative FFQ, diet over the last 3 monthsAHEI-2010 [65]
Alcohol consumption was not included
Birthweight, large- and small-for-gestational ageNo associations were found with birth anthropometry
Shapiro et al., 2016 [102]United States, 2014The Healthy Start cohort, a pre-birth observational cohort1079 singleton mother-offspring pairs, without prior medical historySelf-Administered 24-h dietary recalls during pregnancyHEI-2010 [64]
Exclusion of alcohol consumption
Neonatal adiposityHaving an HEI-2010 score ≤57 (poorer diet quality) was significantly associated with higher %fat mass
Poon et al., 2013 [101]US, 2005–2007The Infant Feeding Practices Study II, a prospective cohort study830 women included for analyses after exclusion of women with diabetesSelf-completed Diet History Questionnaire during the third trimester that reflects dietary intake between 28 and 36 weeks of gestationAlternative Healthy Eating Index for Pregnancy (AHEI-P) updated from the updated AHEI-2010 alcohol was excluded, while calcium, folate, and iron were added to the scoring methodBirthweight z-scores and weight-for-length z-scoresMaternal diet quality was not associated with birth anthropometry
Rodriguez-Bernal et al., 2010
[99]
Spain, 2004
2005
The Valencia birth cohort—A subproject of the INMA study787 women and their newbornsFFQ, administered by trained interviewers during the first trimester of pregnancyAHEI adapted for pregnancy **
To make the index more appropriate for the pregnant population, they excluded the alcohol intake and long-term multivitamin use. They added folate, iron, and calcium intakes [106]
Birth weight, birth length, and head circumference at birthNewborns of women in the fourth quintile were heavier and longer than those in the lowest quintile.
Decreased risk of foetal growth-restricted infant for weight in women with the highest AHEI.
Rifas-Shiman et al., 2009 [75]US, 1999–2002Project Viva: prospective cohort study1777 women with singleton live birthsSelf-administered semi-quantitative FFQ assessing the woman’s diet during early pregnancy and the second trimesterAHEI-P: Exclusion of alcohol, nuts and soy protein component and inclusion of tofu or soybeans in the vegetable component,
folate, iron, and calcium
Birth weight for gestational age categories: small and large for gestational ageNo associations with foetal growth
* HEI-SGP: Fruit and vegetables (0–20 points), rains (0–20 points), meat and others (0–20 points), total fat (0–10 points) and total saturated fat (0–10 points); and last, the use of antenatal supplements containing iron, folate and calcium (0–10 points).** AHEI consisted of intake of 9 items: Vegetables (5 servings/d),fruit (4 servings/d), nuts and soy (1 serving/d), ratio of white meat (fish and poultry) to red meat (≥4:1), cereal fibre (15 g/d),trans fat (≤0.5% of energy), ratio of polyunsaturated to saturated fat (≥1), moderate alcohol intake (0.5–1.5 servings/d) and long-term multivitamin use (≥5 y of continuous use).
Table 5. Individual studies on the associations between maternal DASH scores and birth outcomes.
Table 5. Individual studies on the associations between maternal DASH scores and birth outcomes.
First Author, YearCountry or SettingStudy DesignPopulationDietary Assessment Method/Intervention and PeriodAssessment of Adherence to the DietBirth OutcomesKey Findings
Jiang et al., 2019 [82]China, 2015–2017Randomized controlled Trial85 pregnant women diagnosed with gestational or chronic hypertensionIntervention: DASH diet vs. control (usual diet), randomly assigned at 12 weeksThe Dietary Approaches to Stop Hypertension (DASH) diet was modified to accommodate specific needs of pregnancies. The diet was similar to the control diet in terms of macronutrients (50–60% carbohydrate, 20–25% fat and 20–25% protein); however, it was rich in fruits, vegetables, whole grains and low-fat dairy products; low in saturated fats, cholesterol and sweets. The amount of salt intake was 4g/d.Prematurity, birth weight, body length and Apgar scoreBeneficial effects on the incidence of prematurity, low birth weight and infant body length
Van Horn et al., 2018 [109]USA, 2012–2015Maternal Offspring Metabolics Family Intervention Trial (MOMFIT): Randomized controlled Trial281 overweight/obese women randomized at 16-week gestationIntervention DASH diet vs. usual care. The two groups received the 2008 Physical Activity Guidelines for Americans.Second and third trimester of pregnancyMinor modifications to the DASH diet, called MAMA-DASH, were calorically suited to the restricted weight gain recommendations, and followed nutrition guidelines for pregnant women, including avoidance of fish considered higher in mercury, inclusion of calcium-rich, vitamin D−enriched dairy, or calcium-fortified non-dairy productsNewborn anthropometryNo significant differences in birth anthropometric measurements, percentage body fat
Fulay et al., 2018 [110]USA, 1999–2002Project VIVA: longitudinal cohort study1760 women included with a singleton pregnancySemi-quantitative FFQ, at study enrolment in the first trimester of pregnancyCalculation of two dietary patterns: DASH diet and
DASH OMNI pattern, which is based on the original DASH diet supplemented by higher unsaturated fat intake
Birth size and preterm deliveryAdherence to neither DASH or DASH OMNI diet during early pregnancy were associated with prematurity or birth anthropometry
Vesco et al., 2015 [108]USA, 2009–2011Randomized controlled Trial114 obese women randomized between 7–21 weeks’ gestationDASH diet with least 30 min of moderate physical activity vs. control group who received one time advice session without any particular focus on DASH diet or weight managementEnergy reduced eating plan, based on DASH dietary pattern without sodium restriction.Small and large for gestational age, weight-for-gestational-age z-score, macrosomiaIntervention group had lower risk of having LGA infant
Martin et al., 2015 [111]USA, 1995–2000PIN (Pregnancy, Infection, and Nutrition): Prospective cohort study3143 pregnant women includedSelf-administered FFQ 26–29 weeks of gestationDASH diet was characterized positively by intake of fruits, vegetables, nuts and legumes, low-fat dairy and whole grains.
Sodium, red and processed meats, and sweetened beverage were reversed-scored
Premature birthGreater adherence to the DASH diet is associated with decreased odds of prematurity compared with women in the lowest quartile
Asemi et al., 2014 [78]Iran, 2013Randomized controlled Trial52 women diagnosed with gestational diabetes mellitusIntervention: DASH diet for 4 weeks during pregnancy vs. control diet with similar calorie content and protein compositionDASH diet was rich in fruits, vegetables, whole grains and low-fat dairy products, and low in saturated fats, cholesterol, refined grains and sweets. The amount ofsodium intake was 2400 mg per dayBirthweight, Birth length, Head circumference at birth, Ponderal Index, Apgar score, Macrosomia, Polyhydramnios, Gestational ageLower birth weight, head circumference and ponderal Index in the intervention group
Table 6. Individual studies on the associations between maternal glycaemic index and birth outcomes.
Table 6. Individual studies on the associations between maternal glycaemic index and birth outcomes.
First Author, YearCountry or SettingStudy DesignPopulationDietary Assessment Method/Intervention and PeriodAssessment of Adherence to the DietBirth OutcomesKey Findings
Wahab et al., 2020
[35]
Netherlands, 2002–2006Generation R: Population-based prospective birth cohort study3471 pregnant women without any medical conditionsSemi-quantitative FFQ in first trimesterGI values were obtained from the glycaemic index database on the Dutch diet published by the Medical Research Council Human Nutrition Research
Calculation of the GI and GL
Foetal growth in mid and late pregnancy
Birth weight, risk of SGA, LGA,
Preterm birth
Higher maternal early pregnancy GL was associated with a higher foetal abdominal circumference and estimated foetal weight in late pregnancy.
Higher maternal early pregnancy GI was associated with a lower risk of a large-for-gestational-age infant
Chen et al., 2019 [38]Ireland, 2001Lifeways study: Prospective cohort study842 mother–child pairs with singleton live birthsSemi-quantitative FFQ, self-completed at the first 12–16 weeks of pregnancyTo calculate dietary GI and GL, food items listed in the FFQ were matched to corresponding food items in databases with published GI values. Average participant GL was derived by summing the food intake frequency-weighted GL for all food items. The average dietary GI of participants was calculated by dividing their GL by their total available carbohydrate intake, then multiplying by 100.Birth weight, macrosomia, gestational ageNeither glycaemic nor insulinemic responses to diet during early pregnancy appear to be associated with offspring birth weight, gestational age, BMI at birth
Gomes et al., 2019 [40]Brazil, 2012–2013Cohort study259 womenTwo 24-h dietary recalls in each gestational trimesterThe dietary GI and GL values were obtained from the Nutrition Data System for Research software.Calculated for the second and third trimesterBirth weight z-score calculated using the e Intergrowth-21st ProjectNo association between GI/GL and birth weight were observed
Horan et al., 2016 [113]Ireland, 2007–2011The ROLO study: Randomized controlled trial280 mother-infant pairs. Participants were secundigravida women with a previous macrosomic baby (>4 kg).Low GI dietary advice vs. usual antenatal care, which did not involve dietary advice.
3-day food diaries were completed at each trimester of pregnancy
GI values were determined using the 2008 International Tables of GI values and other recently published GI valuesOffspring adiposity at 6 monthsNo difference was found in 6 months infant adiposity between control and intervention groupsbut maternal trimester 3 GI was positively associated with 6 months old triceps skinfold thickness for age z-score and biceps skinfold thickness
Moses et al., 2014 [114]Australia, 2010PREGGIO (Pregnancy and Glycaemic Index outcomes): A randomized controlled trial576 women without any medical conditionsLow GI dietary advice at the first antenatal visit vs. healthy eating diet. Participants were provided with 1 of 2 sets of booklets (depending on their allocation) that included information on the choices for and serving sizes of carbohydrate-rich foods. No intended difference in the macronutrient distribution in dietsDatabase incorporated Australian food-composition tables and published GI valuesThe dietary GI was calculated as the weighted sum of the GI of all carbohydrate (CHO) foods in the diet, with the weighting proportional to the contribution of each food to total CHO intake. Glycaemic load is the product of the GI and amount of CHO.Birth anthropometry and ponderal indexNo significant differences in foetal birth weight, length, and ponderal index between the two groups. GL was the only predictor of birth percentile and ponderal index.
Knudsen et al., 2013 [83]Denmark, 1996–2002Danish national birth cohort: Prospective birth cohort study41,782 first trimester pregnant womenSelf-administered FFQ in week 25 of gestationValues of the GI were extracted from published data and were incorporated into the dietary database.
Calculation of the GI and GL
Birth weight, SGA or LGA risksMean of birthweight was higher in the highest GL quintile compared to the lowest and increased risk of LGA was observed in the highest GL quintile.
Walsh et al., 2012 [81]Ireland, 2007–2011The ROLO study: Randomized controlled trial800 secundigravida women with a previous macrosomic baby (>4 kg).Low GI diet from 14 weeks gestation to delivery vs. no dietary intervention. Research dietitian met the patients at 28 and 34 weeks’ gestation.Women were encouraged to choose as many low GI foods as possible and to exchange high GI carbohydrates for low GI alternatives. Women were not advised to reduce their total caloric intake.Birth weightNo significant difference was seen between the two groups in absolute birth weight, birth length, head circumference or ponderal index at birth
Perichart-Perera et al., 2012 [112]Mexico, 2004–2008Randomized controlled trial107 women recruited with gestational diabetes or pregestational type 2 diabetes mellitusControl group (n = 61): women received an individual food plan based on CHO restriction. Women in this group were advised to choose any type of CHO, except added refined sugars.
Intervention group (n = 46): women were counselled to eliminate all moderate and high GI foods (GI > 55)
Energy and CHO prescriptions were revised at every visit and changes were done according to weight gain
Educational themes included the importance of healthy eating with diabetes, identification of CHO, exchange lists and CHO counting, identification of high and low GI foods, healthy fats and importance of capillary glucose self-monitoring.
Significant decrease in the GI in the interventional group
Birth anthropometry measurements, macrosomia, prematurity,A trend of lower birthweight was observed in the intervention group without risk of SGA. Higher frequency of premature birth was observed in the intervention group.
Table 7. Studies investigating maternal dietary scores and long-term offspring outcomes.
Table 7. Studies investigating maternal dietary scores and long-term offspring outcomes.
First Author, YearCountry/SettingStudy DesignPopulationMaternal Dietary Assessment Method Assessment of Adherence to Diet/Dietary ScoreLong-term Outcome/Median Child AgeKey Findings
Callanan et al., 2021 [115]Ireland2007–2011Randomized controlled trialThe ROLO study387 mother–child pairs3-day food diary during each trimester of pregnancyLow GI diet from 14 weeks gestation to delivery vs. no dietary interventionLow eucaloric GI diet (dietary education sessions with a research dietitian) vs. control
(routine antenatal care)
Anthropometry and child adiposity at 5 yearsNo significant associations were found between low GI in pregnancy RCT group and child weight/body composition outcomes (these included weight, BMI, centiles, waist–hip ratio, central adiposity, total fat mass and total lean mass) at 5 years follow-up.
Strohmaier et al., 2020 [116]USARetrospective observational analysis of the Nurses’ Health Study II (NHSII) and Growing Up Today Study II (GUTSII) cohorts.2729 mother–child pairsFFQof habitual diet within last 12 months during peripregnancy periodAHEI-2010 [65], Alternate Mediterranean Diet (aMED) (Trichopoulou’s score modified for pregnancy) and DASH based on 8 components (fruits, vegetables, nuts and legumes, low-fat dairy and whole grains, sodium, red and processed meat and sugar-sweetened beverages)Anthropometry-overweight and obesity, 12–23 yearsGreater maternal adherence to aMED and DASH, but not AHEI, was associated with lower overweight risk in the offspring (RRQ5 vs Q1 = 0.82 for aMED and 0.86 for DASH, P for trend <0.05 for both) but none of the 3 scores remained significantly associated with offspring overweight or obesity risk after further adjustment for maternal pre-pregnancy BMI and lifestyle factors (maternal smoking status and physical activity) before pregnancy
Maslova et al., 2019 [117]DenmarkPopulation-based cohort study-Danish National Birth Cohort (DNBC)68,471 mother–offspring pairs360-items semi-quantitative FFQ during mid-pregnancy (25-week gestation)Reference of GI were retrieved from published data relevant to the time period ofenrolment
Calculation of the GI and GL per day
Age- and sex-specific BMI z scores and growth velocities at 7 yearsHigher maternal GI and GL were associated with an increase in the 7-year BMI z score in the unadjusted analysis; association was not significant in adjusted analysis. Children of underweight women showed a potential higher risk of overweight/obesity at age 7 with higher maternal GI and GL, but with wide confidence intervals.
Chen et al., 2019 [38]IrelandProspective cohort-Lifeways Cross-Generation Cohort Study842 mother–child pairsFFQduring the first 12–16 weeks of pregnancyFood items were matched to corresponding food items in databases with published GI values using a UK database. Calculation of the GI, GL, II and ILChildren’s body mass index (BMI) and waist circumference at 5 yearsNo association was observed for scores with BMI & waist circumference z-scores and childhood obesity (general and central) at 5-y follow-up
Gonzalez-Nahm et al., 2019 [118]Southwestern USAProspective cohort-Nurture Study623 mother–infant pairsFFQ during 2nd-3rd trimesterAHEI-2010 [65]
(excluding alcohol)
Anthropometry, at birth, 6 months, 12 monthsAfter adjustment, maternal AHEI-2010 was not associated with infant adiposity at birth, 6 or 12 months.
Tahir et al., 2019 [119]USA Prospective cohort-MILK Study354 mother–infant pairsFFQ3rd trimester, 1 month postpartum, 3 months postpartumHEI-2015 [57]Anthropometry at birth, 1 month, 3 months and 6 monthsA 10-unit increase in HEI–2015 total scores during pregnancy was associated with an approximately 0.6% lower infant body fat% at six months (β = −0.58, p = 0.05).
Navarro et al., 2019 [24]Ireland Prospective cohort-Lifeways Cross-Generation Cohort Study1082 child–mother pairs; 585 childrenFFQduring the first12–16 weeks of pregnancyE-DII (as described in Table 2)Anthropometric Outcomes
5 years and 9 years
No associations were found between maternal E-DII scores and offspring overweight and/or obesity at 5 and 9 years
Navarro et al., 2019 [104]Ireland Prospective cohort-Lifeways Cross-Generation Cohort Study1082 child–mother pairs; 585 childrenFFQduring the first 12–16 weeks of pregnancyHEI-2015 [57]Anthropometric Outcomes at 5 yearsNo associations between maternal HEI scores and childhood overweight or obesity; higher paternal HEI scores were associated with lower odds ratios of childhood obesity at 5 years old
Sen et al., 2018 [84]USA Longitudinal cohort-Project Viva922 mother–child pairsValidated semi quantitative FFQ completed between 10-28-week gestationDII calculated based on
28 dietary parameters: energy, carbohydrate, protein, fat, alcohol, fibre, cholesterol, SFAs, MUFAs, PUFAs, n–3 and n–6 FAs, trans-fat, niacin, thiamin, riboflavin, vitamin B-12, vitamin B-6, iron, magnesium, zinc, selenium, vitamin A, vitamin C, vitamin D, vitamin E, folic acid, and β-carotene.
Anthropometric Outcomes
(range 6–10 years, median 7.7 years)
Higher maternal DII in pregnancy was directly associated with offspring size in mid-childhood, including BMI z-score, fat-free mass index and waist circumference as well as more direct measures of adiposity and dysmetabolism, including fat mass index, trunk fat mass index and fasting insulin
Chatzi et al., 2017 [120]USA and Greece Population-based prospective cohorts1566 mother–child pairsFFQ during 1st trimesterMDS ranging from 0–9, Trichopolous score modified based
on recommendations for pregnant women [71]
Child adiposity, blood pressure and cardiometabolic parameters
Mid-childhood (median 7.7 years USA; median 4.2 years Greece)
For each 3-pt increment in the MDS:
offspring BMI z-score was lower by 0.14 units (95% CI, −0.15 to −0.13),
waist circumference by 0.39 cm (95% CI, −0.64 to −0.14),
the sum of skin-fold thicknesses by 0.63 mm (95% CI, −0.98 to −0.28).
lower offspring systolic (−1.03 mmHg; 95% CI, −1.65 to −0.42) and diastolic blood pressure
Fernandez-Barres et al., 2016 [121]SpainPopulation-based ‘Infancia y Medio Ambiente’ (INMA) birth cohort study1827 mother–child pairsFFQ during 1st and 3rd trimesterRelative Mediterranean diet score (rMED), final potential score range was 0–16Anthropometry-Overweight/obesity and abdominal obesity based on waist circumference at 4 yearsHigher adherence to the MD in pregnancy was not associated with offspring overweight at age 4 years, but there was some evidence of an inverse, moderate association between maternal rMED scores in pregnancy and offspring waist circumference
Okubo et al., 2014 [122]UKProspective cohort – Southampton Women’s Survey906 mother–child pairsFFQBetween 11–34-week gestationGI and GL
GI values were obtained from the GI database published by the Medical Research Council Human Nutrition Research, UK
The GL of each food item was determined by multiplying the carbohydrate content of one serving by its GI value (divided by 100)
Body fat mass and lean mass, 4 years and 6 yearsMaternal dietary GI in early (11 weeks) pregnancy was positively associated with fat mass at 4 and 6 years of age. Maternal dietary GI in late (34 weeks) pregnancy was also positively associated with fat mass at 4 and 6 y of age, but these associations were not robust to adjustment for confounding factors
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lecorguillé, M.; Teo, S.; Phillips, C.M. Maternal Dietary Quality and Dietary Inflammation Associations with Offspring Growth, Placental Development, and DNA Methylation. Nutrients 2021, 13, 3130. https://doi.org/10.3390/nu13093130

AMA Style

Lecorguillé M, Teo S, Phillips CM. Maternal Dietary Quality and Dietary Inflammation Associations with Offspring Growth, Placental Development, and DNA Methylation. Nutrients. 2021; 13(9):3130. https://doi.org/10.3390/nu13093130

Chicago/Turabian Style

Lecorguillé, Marion, Shevaun Teo, and Catherine M. Phillips. 2021. "Maternal Dietary Quality and Dietary Inflammation Associations with Offspring Growth, Placental Development, and DNA Methylation" Nutrients 13, no. 9: 3130. https://doi.org/10.3390/nu13093130

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop